2021 AAD ELECTION BALLOT BOOK

the mailing instructions at the top of the ballot. 01. 2021 ... Election of 2021 Officers, Board of Directors and Nominating Committee Member ...

2021 AAD ELECTION BALLOT BOOK View Election Materials and Vote for Officers, Directors of the Board of Directors & Nominating Committee Member Representative VOTING OPENS: Saturday, March 20 at 12:01 A.M. (ET) DEADLINE TO VOTE: Saturday, April 3 by 11:59 P.M. (ET) AAD ELECTION CONNECTION: AAD.org/election DIRECT VOTING LINK: https://vote.escvote.com/aad ACCESS CODE OR PERSONALIZED VOTING LINK ACCESS CODES will be mailed to eligible voting members without email on file with the AAD on February 24 and March 20. Use the Access Code along with your AAD Member ID Number to login and vote. PERSONALIZED VOTING LINKS will be emailed to eligible voting members with email on file with the AAD on March 20, 22, 24, 26, 30, April 1, 2 and 3. Click on the personalized voting link embedded in the email to access the direct voting site. Your personalized voting link is only accessible via the email notifications. NEED ASSISTANCE Please call Election Services Corporation (ESC) toll-free (866) 720-4357 during business hours Monday thru Friday 9 a.m. 5 p.m. (ET) or send an email to aadhelp@electionservicescorp.com NOTE: ESC staff will be available at the above toll-free number and by email on Saturday, March 20 and Sunday, March 21 from 8 a.m. until 5 p.m. (Central Time) to assist members with their access code. VOTING BY MAIL Members are encouraged to vote via the AAD Election Connection at www.aad.org/election to ensure your vote is electronically posted by Saturday, April 3 at 11:59 PM (ET). If you prefer to vote by mail, please refer to the mailing instructions at the top of the ballot. PRESIDENT-ELECT CANDIDATES HAVE AGREED TO ABIDE BY THE FOLLOWING EXCERPT FROM THE ADMINISTRATIVE REGULATION ON CODE FOR INTERACTIONS WITH COMPANIES Direct Financial Relationship8: A Direct Financial Relationship is a relationship held by an individual that results in wages, consulting fees, honoraria, or other compensation (in cash, in stock options, or in kind), whether paid to the individual or to another entity at the direction of the individual, for the individual's services or expertise. As used in this Code, the term Direct Financial Relationship does not mean stock ownership or intellectual property licensing arrangements. See Principle 1.4 for additional clarification of the meaning of Direct Financial Relationship. 8 Definition: A Direct Financial Relationship is a compensated relationship held by an individual that should generate an IRS Form W-2, 1099 or equivalent income report. Key Society Leaders (including the President, President-Elect, Immediate Past President, the Secretary-Treasurer, Assistant Secretary-Treasurer, the chief executive officer of a Society's membership organization, and the Editor(s)-in-Chief of Society Journal(s)" may provide uncompensated service to for-profit health care products companies ("Companies") and accept reasonable travel reimbursement in connection with those services. Key Society Leaders may accept research support as long as grant money is paid to the institution (e.g., academic medical center) or practice where the research is conducted, not to the individual. Exception may be made in certain circumstances for provision of consultant or investigator expertise related to protocol development and/or safety monitoring or any other consulting work related to one's own past, current or potential research studies as long as the activities are not related to marketing or promotional efforts. In this event, the Secretary-Treasurer must be provided with background information and approval must be provided in advance for an exception to the policy. In these circumstances, compensation to the individual may not exceed $10,000/company/year. Verifying 1099 forms must be submitted to the Secretary-Treasurer when received. This exception may not be applied to the President, who shall remain free from any and all direct financial relationships during his/her term of office. 01 2 TABLE OF CONTFEirNsTt Sname Last name, CREDS Table of Contents ......................................................................................................................................... 3 President's Letter ......................................................................................................................................... 5 AAD Proposed Amendments and Statements in Support of or in Opposition to ............................. 6-10 AADA Proposed Amendments and Statements in Support of or in Opposition to ........................ 11-12 AAD 2019 and 2020 Annual Business Meeting Minutes .................................................................... 13-17 AADA 2019 and 2020 Annual Business Meeting Minutes ................................................................. 18-19 Election of 2021 Officers, Board of Directors and Nominating Committee Member Representative In accordance with the Bylaws of the American Academy of Dermatology the following Academy fellows have been nominated. The nominees, in random order, are: Office of President-Elect Terrence A. Cronin, Jr., MD, FAAD .............................................................................................................. 20 Susan C. Taylor, MD, FAAD......................................................................................................................... 21 Office of Vice President-Elect Robert S. Kirsner, MD, PhD, FAAD .............................................................................................................. 22 Valerie D. Callender, MD, FAAD .................................................................................................................. 23 Board of Directors Adrian O. Rodriguez, MD, FAAD.................................................................................................................. 24 Sarah C. Jackson, MD, FAAD ...................................................................................................................... 25 Tammie Ferringer, MD, FAAD...................................................................................................................... 26 Robert Sidbury, MD, PhD, FAAD ................................................................................................................. 27 Ruth Ann Vleugels, MD, MPH, MBA, FAAD................................................................................................. 28 Brad P. Glick, DO, MPH, FAAD.................................................................................................................... 29 Sabra Sullivan, MD, PhD, FAAD .................................................................................................................. 30 Melissa P. Piliang, MD, FAAD ...................................................................................................................... 31 Nominating Committee Member Representatives Andrew F. Alexis, MD, MPH, FAAD ............................................................................................................. 32 Craig N. Burkhart, MD, MPH, MSBA, FAAD ................................................................................................ 33 Excerpt of Nomination and Election Procedure Administrative Regulation..................................... 34-35 The views and opinions expressed by the candidates are their own and do not necessarily reflect those of the Academy or its policies. 3 4 March 2021 Dear Colleague: The Academy's election opens on March 20; use your vote to help shape its future. The power is in your hands to ensure the Academy remains an effective organization that makes us proud to be its members. Cast your vote for the leaders who reflect what is important to you -- whether it is your career goals or concerns impacting our specialty and patients. Be a changemaker and join me by voting online at aad.org/election during the two-week voting period, March 20 to April 3. Ballots must be received Saturday, April 3 at 11:59 p.m. (ET). Please take a few minutes to visit the AAD Election Connection, aad.org/election to: · Learn about the candidates and view their videotaped statements; · Submit questions to the "Ask the Candidate" forum; · Get information about the Officer Town Hall; and · Easily cast your vote. The nationally respected firm, Election Services Corporation (ESC), will handle management and oversight of the election process. Thank you for your ongoing commitment to the Academy and for your participation in the 2021 election. Sincerely, Bruce H. Thiers, MD, FAAD President 5 AAD PROPOSED BYLAWS AMENDMENT AND STATEMENTS IN SUPPORT OF OR OPPOSITION TO Additions shown as bold and underlined Deletions shown as stricken Recommendation by the AAD Board of Directors: Approve ARTICLE V Meetings of Members Section 2. Special Meetings Special meetings of the members of the Academy may be called only by the Board of Directors or by written petition signed by the lesser of 50 members with voting rights or at least ten (10) percent of the voting members of the Academy and unless otherwise provided by law, may be held at any time and place designated by the Board of Directors. Section 3. Notice Notice of any annual or special meeting of the members shall be given not less than ten (10) nor more than thirty (30) days prior thereto by written notice delivered personally, or by mail or electronic communications, by or at the direction of the President or the Secretary-Treasurer, to each member of the Academy. Such notice shall state the place, day, and hour of the meeting and in the case of a special meeting shall also state the purpose or purposes for which it is called. Section 4. (a) Quorum Three (3) percent of the total Not less than two hundred and fifty (250) voting membership of the Academy in good standing, but not less than two hundred and fifty (250) members with voting rights, shall constitute a quorum at any meeting of members. There shall be no representation by proxy at the annual meeting of members. The Board of Directors may, in its discretion, provide for proxy voting by members at any special meeting of members. Section 5. Voting On any matter to be voted upon at any annual or special meeting of members, each member with voting rights shall be entitled to one (1) vote. Except as provided in Section 4(a) of this Article V, there shall be no voting by proxy or cumulative voting. The act of a majority of the members present and voting at a meeting at which a quorum is present shall be the act of the membership of the Academy, except where otherwise provided by law or these bylaws, and except that voting for the election of directors, the President-elect, and the Vice President-elect, and voting upon any proposed amendment to these bylaws or the articles of incorporation of this corporation, and other matters designated in these bylaws or the administrative regulations, or by two-thirds vote of the Board of Directors, shall be by electronic and/or other written ballot. Ballots shall be sent to all members eligible to vote, and the specific procedure for conducting the vote shall be as set forth in the administrative regulations of the Academy. ARTICLE VI Board of Directors Section 2. Number, Tenure and Qualifications The Board of Directors shall consist of sixteen (16) elected directors and the officers of the Academy, the immediate past President of the Academy and the Chairman of the Advisory Board of the Academy, all of whom shall be ex-officio directors. The Executive Director shall be an ex-officio, non-voting member of the Board of Directors. As provided in the Association's bylaws, the directors of the Academy shall also serve as the directors of the Association. The elected directors shall take office at the conclusion of the annual membership meeting at which time they are inducted, as provided in the administrative regulations, and shall serve for a term of four (4) years and until their successors shall be duly elected and qualified; provided, however, that the terms of the elected directors shall be staggered so that four (4) directors shall be elected prior to each annual membership meeting to succeed 6 AAD PROPOSED BYLAWS AMENDMENT AND STATEMENTS IN SUPPORT OF OR OPPOSITION TO the four (4) directors whose terms shall expire at that meeting. Elected directors and the Chair of the Advisory Board may serve only one four (4)-year term; except that an individual who is appointed or elected under Section 4 of this Article VI to fill a vacancy in an open director position for no more than two years is still eligible to serve a full term as an elected director or as Chair of the Advisory Board. An individual who serves as an Advisory Board Chair shall not be eligible to subsequently serve as an elected director. The officers of the Academy shall serve as members of the Board of Directors during their terms as officers, and the immediate past President shall serve as a member of the Board of Directors for the period described in Article VII, Section 3(a), of these bylaws. Ex-officio directors shall have the same rights, authority and responsibilities as the elected directors. With the exception of the Executive Director, only Fellows (or Life or Honorary Members who have been Fellows) of the Academy may serve on the Board of Directors, and no individual shall serve consecutive terms as an elected director. Section 5. (d) Meetings Written notice of the time, place and purposes of each meeting of the Board of Directors shall be delivered to each director not less than fourteen (14) nor more than thirty (30) days prior thereto, except that meetings to discuss business that the President reasonably deems to be urgent may be called on twenty-four (24) hours notice as long as directors are permitted to participate by telephone or other electronic communications means consistent with Section 11 of this Article VI. ARTICLE VII Officers Section 1. Number, Titles and Qualifications The officers of the Academy shall be a President, a President-elect, a Vice President, a Vice President- elect, a Secretary-Treasurer, and an Assistant Secretary-Treasurer. As provided in the Association's bylaws, the officers of the Academy shall also serve as the officers of the Association. Only Fellows of the Academy (or Life or Honorary Members who have been Fellows) in good standing may serve as officers. No two (2) offices may be held simultaneously by the same individual. No individual may serve in the same office for more than consecutive one terms, except that time spent filling a vacancy in an officer position will not be counted against this limitation. No individual may serve simultaneously both as an officer and as one of the sixteen (16) elected directors referred to in Article VI, Section 1 of these bylaws. Any individual who is elected or appointed to an office and an elected directorship with overlapping terms must resign promptly from one of the two positions. The President-elect and the Vice President-elect, at the time of assuming their offices, must each have served at some time for at least one (1) year on the Board of Directors. Nomination, Election and Tenure (c) The terms of office of the officers shall be as follows: (i) The President shall serve for a single term of one (1)-year term commencing with the termination of his or her term as President-elect and terminating at the conclusion of the next annual membership meeting. (ii) The President-elect shall serve for a single one (1)-year term of one (1) year commencing at the conclusion of the annual membership meeting next following his or her election to that office and terminating at the conclusion of the next annual membership meeting. Upon termination of the said term as President-elect, the Fellow shall assume the office of President for a term set Section forth in (i) above. (iii) The Vice President shall serve for a single one (1)-year term of one (1) year commencing with the termination of his or her term as Vice President-elect and terminating at the conclusion of the next annual membership meeting, except as provided in Section 4(a) of this Article. 7 AAD PROPOSED BYLAWS AMENDMENT AND STATEMENTS IN SUPPORT OF OR OPPOSITION TO (iv) The Vice President-elect shall serve for a single one (1)-year term of one (1) year commencing at the conclusion of the annual membership meeting next following his or her election to that office and terminating at the conclusion of the next annual membership meeting. Upon termination of the said term as Vice President-elect, the Fellow shall assume the office of Vice President for a term set forth in (iii) above. (v) The Secretary-Treasurer shall serve for a single three (3)-year term of three (3) years, commencing at the conclusion of the annual membership meeting next following his or her election to that office and terminating at the conclusion of the third annual membership meeting following that meeting. The Secretary-Treasurer shall not be eligible to be on the ballot in an election for officer or director during their term of office and during any election cycle that occurs in whole or in part during their term of office. (vi) The Assistant Secretary-Treasurer shall serve for a single three (3)-year term of three (3) years commencing at the conclusion of the annual membership meeting next following his or her election to that office and terminating at the conclusion of the third annual membership meeting following that meeting. ARTICLE X Administrative Regulations Section 3. Amendment The administrative regulations of the Academy may be amended by the Board of Directors at any meeting by a two-thirds vote, provided that notice of any proposed amendment shall have been given to each director not less than fourteen (14) nor more than thirty (30) days prior thereto; provided that such notice requirement shall not apply to (a) subsequent amendments to the same administrative regulation during the meeting for which notice of the initial proposed amendment has been duly provided, or (b) if the Board of Directors waives such notice requirement by a two-thirds vote. Alternatively, the administrative regulations may be amended by the membership by a two-thirds vote of the members voting thereon by electronic and/or mail or other written ballot conducted pursuant to Article V, Section 5 of these bylaws and the relevant procedures in the administrative regulations, provided that any such proposed amendment shall have been presented to the Secretary-Treasurer prior to the preceding annual membership meeting in a petition subscribed by at least two and one-half ten percent (2.510%) of the voting members of the Academy and identifying no more than three signatories authorized to speak and act for all petitioners, and provided further that written notice of any such proposed amendment shall have been given to each member eligible to vote thereon and shall otherwise follow the notice procedures for amending these bylaws set forth in Article XVII and the administrative regulations. ARTICLE XII Committees Section 1. Standing Board Committees In addition to the Executive Committee authorized by Article VI, Section 7, of these bylaws, the Board may establish such other standing Board committees as it shall deem necessary or appropriate to conduct the affairs of the Academy. The Board of Directors may designate committees by whatever name or names the Board shall deem appropriate; by way of illustration but not limitation, such names may include committee, council, commission, section, panel, workgroup, task force or ad hoc task force. The administrative regulations of the Academy shall set forth the purposes, duties, powers, composition, manner and term of appointment and method of operation of such standing Board committees. 8 AAD PROPOSED BYLAWS AMENDMENT AND STATEMENTS IN SUPPORT OF OR OPPOSITION TO Section 4. Standing Board Committees The Board of Directors may designate committees by whatever name or names the Board shall deem appropriate; by way of illustration but not limitation, such names may include committee, council, commission, section, panel, work group, task force or ad hoc task force. Section 45. Termination Notwithstanding any other provision of these bylaws or the administrative regulations of the Academy, a new standing Board committee or sub-committee may be created, or any standing Board committee or subcommittee may be terminated, by action of the Board of Directors. Any special committee may be terminated by action of the Board of Directors at any meeting, provided that notice of such proposed termination shall have been given to all directors not less than fourteen (14) nor more than thirty (30) days prior thereto. ARTICLE XVII Amendments Section 2. Other Proposals Any proposed amendment to these bylaws or to the articles of incorporation of this corporation which shall not have been approved by the Board of Directors by a two-thirds vote may be adopted by a two-thirds vote of the members voting thereon through an electronic and/or mail or other written ballot conducted pursuant to Article V, Section 5, of these bylaws, provided that any such proposed amendment shall have been presented to the Secretary-Treasurer at the preceding annual membership meeting in a petition subscribed by at least two and one- half ten percent (2.510%) of the voting members of the Academy and identifying no more than three signatories authorized to speak and act for all petitioners, and provided further that written notice of any such proposed amendment shall have been given to each member eligible to vote thereon. BOARD STATEMENT REGARDING THE PROPOSED AAD & AADA BYLAWS AMENDMENTS In 2020, the Board of Directors tasked the Bylaws Committee to review aspects of our AAD and AADA bylaws to bring them in line with an organization the size and scope of the Academy, which has grown to over 15,000 voting members from 10,252 voting members in 2000 when the existing bylaws amendment was established. Among the recommended updates are changes to the minimum number of voting members needed to call a special meeting as well as to bring forward a petition to change the bylaws. The Bylaws Committee recommended, and the Board agreed that 10% was a reasonable percentage to require for these situations and would reflect the interest and will of a significant portion of the voting membership. Another proposed change to the bylaws focuses on term limits for directors, including the Advisory Board chair, and officers. The proposed changes prohibit a director or an officer from being considered for an office they have already held unless that individual is filling an unanticipated vacancy to complete the term of another officer or director who departed before the end of their term. In such a case, that service would not be counted towards this limitation. This change is intended to assure leadership opportunities and diversity of perspectives on the Academy's Board. The rest of the proposed edits are technical edits to streamline the bylaws. The Board is asking for your yes vote on the proposed bylaws amendments. STATEMENT IN SUPPORT OF THE PROPOSED BYLAWS AMENDMENTS I agree with the amendments to our bylaws. These changes will better keep our organization fresh, and vibrant. They will minimize the tendency for AAD officers benefiting personally to greater degree than the members they serve. Wayne H. Fujita, MD, FAAD Aiea, HI 9 AAD PROPOSED BYLAWS AMENDMENT AND STATEMENTS IN SUPPORT OF OR OPPOSITION TO STATEMENT IN OPPOSITION TO THE PROPOSED BYLAWS AMENDMENTS I stand strongly opposed to the significant portion of the suggested Bylaws changes for 2021. Under the guise of housekeeping changes of language and without introductory comment as to why the Board finds the substantive portion of the Bylaws should be changed, the Bylaws committee and the Board have embarked on an unusual misdirection towards the membership. Altering the requirement for requesting a special meeting from its present 50 members to well over 1500 voting members (i.e. "10%") is an unrealistic and oppressive burden to place on the membership in an organization for whom traditionally only 2732% of voting members choose to vote to select new officers and two-thirds of the majority votes cast are able to change Bylaws (when even 50% of them deign to vote) and less than 1.75% (250) voting members are considered enough to constitute a quorum. If there is a valid explained reason for a change it should be similarly limited to 250 voting members only, which is a reasonable number to achieve by petition. Members in small numbers need to be heard as representative lest the perception of undemocratic elitist self-perpetuating control of the AAD become fixed as it is in the ABD. Gary J. Brauner, MD, FAAD Cresskill, NJ STATEMENT IN SUPPORT OF THE PROPOSED BYLAWS AMENDMENTS I agree with proposed amendments for both AAD and AADA bylaws. Geoffrey F.S. Lim, MD, FAAD Centennial, CO STATEMENT IN SUPPORT OF THE PROPOSED BYLAWS AMENDMENTS I agree with AAD recommendations of bylaws amendments. James V. Allen, MD, FAAD Leawood, KS AADA PROPOSED BYLAWS AMENDMENT AND STATEMENTS IN SUPPORT OF OR OPPOSITION TO Recommendation by the AAD Board of Directors: Approve ARTICLE V Meetings of Members Section 2. Special Meetings Special meetings of the members of the Association may be called only by the Board of Directors or by written petition signed by the lesser of 50 members with voting rights or at least ten (10) percent of the voting members of the Association and unless otherwise provided by law, may be held at any time and place designated by the Board of Directors. Section 3. Notice Notice of any annual or special meeting of the members shall be given not less than ten (10) nor more than thirty (30) days prior thereto by written notice delivered personally, or by mail or electronic communications, by or At the direction of the President or the Secretary-Treasurer, to each member of the Association. Such notice shall state the place, day, and hour of the meeting, and in the case of a special meeting shall also state the purpose or purposes for which it is called. 10 AADA PROPOSED BYLAWS AMENDMENT AND STATEMENTS IN SUPPORT OF OR OPPOSITION TO Section 4. (a) Quorum Three (3) percent of the total Not less than two hundred and fifty (250) voting membership of the Association in good standing, but not less than two hundred and fifty (250) members with voting rights, shall constitute a quorum at any meeting of members. There shall be no representation by proxy at the annual meeting of members. The Board of Directors may, in its discretion, provide for proxy voting by members at any special meeting of members. Section 5. Voting On any matter to be voted upon at any annual or special meeting of members, each member with voting rights shall be entitled to one (1) vote. Except as provided in Section 4(a) of this Article V, there shall be no voting by proxy or cumulative voting. The act of a majority of the members present and voting at a meeting at which a quorum is present shall be the act of the membership of the Association, except where otherwise provided by law or these bylaws, and except that voting for the election of directors, the President-elect, and the Vice President- elect, and voting upon any proposed amendment to these bylaws or the articles of incorporation of this corporation, and other matters designated in these bylaws or the administrative regulations, or by two-thirds vote of the Board of Directors, shall be by electronic and/or other written ballot. Ballots shall be sent to all members eligible to vote, and the specific procedure for conducting the vote shall be as set forth in the administrative regulations of the Association. ARTICLE VI Board of Directors Section 2. Dual Status The Board of Directors of the Academy shall serve as the Board of Directors of the Association. The Board of Directors of the Association shall include the sixteen (16) elected directors of the Academy (the "elected directors") and the officers of the Association, the immediate past President of the Association and the Chairman of the Advisory Board of the Association, all of whom shall be ex-officio directors. The Executive Director shall be an ex-officio, non-voting member of the Board of Directors. The elected directors shall serve as members of the Board of Directors during their terms as directors of the Academy, the officers of the Association shall serve as members of the Board of Directors during their terms as officers, and the immediate past President shall serve as a member of the Board of Directors for the same period served on the Academy Board of Directors. Ex-officio directors shall have the same rights, authority and responsibilities as the elected directors. Section 3. (d) Meetings Written notice of the time, place and purposes of each meeting of the Board of Directors shall be delivered to each director not less than fourteen (14) nor more than thirty (30) days prior thereto, except that meetings to discuss business that the President reasonably deems to be urgent may be called on twenty-four (24) hours notice as long as directors are permitted to participate by telephone or other electronic communications means consistent with Section 9 of this Article VI. ARTICLE IX Administrative Regulations Section 3. Amendment The administrative regulations of the Association may be amended by the Board of Directors at any meeting by a two-thirds vote, provided that notice of any proposed amendment shall have been given to each director not less than fourteen (14) nor more than thirty (30) days prior thereto; provided that such notice requirement shall not apply to (a) subsequent amendments to the same administrative regulation during the 11 AADA PROPOSED BYLAWS AMENDMENT AND STATEMENTS IN SUPPORT OF OR OPPOSITION TO meeting for which notice of the initial proposed amendment has been duly provided, or (b) if the Board of Directors waives such notice requirement by a two-thirds vote. Alternatively, the administrative regulations may be amended by the membership by a two-thirds vote of the members voting thereon by electronic and/or other written ballot conducted pursuant to Article V, Section 5 of these bylaws and the relevant procedures in the administrative regulations, provided that any such proposed amendment shall have been presented to the Secretary-Treasurer prior to the preceding annual membership meeting in a petition subscribed by at least two and one-half ten percent (2.510%) of the voting members of the Association and identifying no more than three signatories authorized to speak and act for all petitioners, and provided further that written notice of any such proposed amendment shall have been given to each member eligible to vote thereon and shall otherwise follow the notice procedures for amending these bylaws set forth in Article XVI and the administrative regulation ARTICLE XI Committees Section 1. Standing Board Committees In addition to the Executive Committee authorized by Article VI, Section 5, of these bylaws, the Board may establish such other standing Board committees as it shall deem necessary or appropriate to conduct the affairs of the Academy. The Board of Directors may designate committees by whatever name or names the Board shall deem appropriate; by way of illustration but not limitation, such names may include committee, council, commission, section, panel, work group, task force or ad hoc task force. The administrative regulations of the Association shall set forth the purposes, duties, powers, composition, manner and term of appointment and method of operation of such standing Board committees. Section 4. Standing Board Committees The Board of Directors may designate committees by whatever name or names the Board shall deem appropriate; by way of illustration but not limitation, such names may include committee, council, commission, section, panel, task force or ad hoc task force. Section 45. Termination Notwithstanding any other provision of these bylaws or the administrative regulations of the Association, a new standing Board committee or sub-committee may be created, or any standing Board committee or council or standing Commission/Council committee may be terminated, by action of the Board of Directors. Any special committee may be terminated by action of the Board of Directors at any meeting, provided that notice of such proposed termination shall have been given to all directors not less than fourteen (14) nor more than thirty (30) days prior thereto. ARTICLE XVI Amendments Section 2. Other Proposals Any proposed amendment to these bylaws or to the articles of incorporation of this corporation which shall not have been approved by the Board of Directors by a two-thirds vote may be adopted by a two-thirds vote of the members voting thereon through an electronic and/or mail or other written ballot conducted pursuant to Article V, Section 5, of these bylaws, provided that any such proposed amendment shall have been presented to the Secretary-Treasurer at the preceding annual membership meeting in a petition subscribed by at least two and one-half ten percent (2.510%) of the voting members of the Association and identifying no more than three signatories authorized to speak and act for all petitioners, and provided further that written notice of any such proposed amendment shall have been given to each member eligible to vote thereon. 12 AAD ANNUAL BUSINESS MEETING MINUTES AMERICAN ACADEMY OF DERMATOLOGY 2019 ANNUAL BUSINESS MEETING MARCH 3, 2019 WALTER E. WASHINGTON CONVENTION CENTER WASHINGTON, DC CALL TO ORDER The 2019 Annual Business Meeting of the American Academy of Dermatology was called to order at 8:15 a.m. (ET) by Suzanne Olbricht, MD, FAAD, President. She stated that this meeting had been called pursuant to the notice requirements set forth in the Academy Bylaws and under Minnesota law. ESTABLISH QUORUM Barbara M. Mathes, MD, FAAD Secretary-Treasurer stated that a quorum (consisting of either 3% or 250 of the voting members) was not initially present but was established prior to the first action item. MEMORIAL Dr. Olbricht asked to begin the morning by honoring our colleagues and friends who have passed away since the last Annual Meeting. INTRODUCTIONS AND ACKNOWLEDGMENTS Dr. Olbricht noted that the Annual Business Meeting booklets were made available online. The Annual Business Meeting booklet contains the annual reports from the Advisory Board, National Institutes of Health, Journal of the American Academy of Dermatology, and American Board of Dermatology. Dr. Olbricht asked the current Officers and members of the Board of Directors to stand and face the audience. She thanked them for all their hard work on behalf of the Academy. She particularly thanked the Immediate Past President, Henry W. Lim, MD, FAAD, Vice President, Ted Rosen, MD, FAAD, Barbara M. Mathes, MD, FAAD Secretary-Treasurer, and members of the Class of 2019 (listed below) for their exceptional service to the Academy. Marc D. Brown, MD, FAAD Janet G. Hickman, MD, FAAD Mark D. Kaufmann, MD, FAAD Gary S. Wood, MD, FAAD Dr. Olbricht asked the following incoming Officers and Directors to stand and noted that they were listed in the Annual Business Meeting booklet. President, George J. Hruza, MD, MBA, FAAD Vice President, Jane M. Grant-Kels, MD, FAAD Secretary-Treasurer, Marta J. Van Beek, MD, MPH, FAAD Assistant Secretary-Treasurer, Daniel D. Bennett, MD, FAAD President-Elect, Bruce H. Thiers, MD, FAAD Vice President-Elect, Susan C. Taylor, MD, FAAD Class of 2023: Lawrence J. Green, MD, FAAD Adelaide Hebert, MD, FAAD Alexander Miller, MD, FAAD Cyndi J. Yag-Howard, MD, FAAD She noted that these Officers and Directors will assume office on Tuesday, March 5, 2019 at the conclusion of the Annual Meeting. She then introduced Executive Director & CEO, Elaine Weiss, and General Counsel, Robert M. Portman, JD, and thanked the Academy staff for their excellent work in putting together this Annual Meeting and for their outstanding service throughout the year. Dr. Olbricht stated that a total of 784 applicants for Fellow, Associate, Affiliate, Adjunct, or International Fellow were accepted into membership this year. She asked the new members to stand and be recognized. Dr. Olbricht introduced the slated 2019 Academy Election Candidates for Officer, Director, and the Nominating Committee Member Representatives (in random order): For President-Elect Kenneth J. Tomecki, MD, FAAD Julie A. Hodge, MD, MPH, FAAD 13 For Vice-President Elect Robert A. Weiss, MD, FAAD Neal Bhatia, MD, FAAD For Board of Director Kathleen Hectorne, MD, FAAD Murad Alam, MD, MSCI, MBA, FAAD Hon S. Pak, MD, MBA, FAAD Naomi Lawrence, MD, FAAD Amy McMichael, MD, FAAD Howard B. Pride, MD, FAAD Jonathan Kantor, MD, MSCE, FAAD Cheryl M. Burgess, MD, FAAD For Nominating Committee Member Representative Roy G. Geronemus, MD, FAAD Mark Lebwohl, MD, FAAD Dr. Olbricht noted that the election opened worldwide on Saturday, March 2 and closes Saturday, March 16. She the described the new features of the AAD Election website that provides members with new sources of information about the candidates and updates about the election, including weekly video updates from Terrence A. Cronin Jr., MD, FAAD. She encouraged the membership to cast their vote for the candidates online from their laptop computer while onsite at the Annual Meeting via the AAD Election Connection or the mobile meeting app. She stated that, to be valid, all ballots must be received by the March 16 deadline. She also stated that all eligible voting members with an email address on file with the Academy received a personalized link on March 2. STATEMENTS FROM CANDIDATES FOR PRESIDENT-ELECT 2019 Dr. Olbricht introduced Dr. Hodge and Dr. Tomecki, candidates for the office of President-Elect. They each made a brief statement in support of their candidacy. RECOGNITION OF INDUSTRY Dr. Olbricht recognized the following Diamond Level Corporate Partners who contributed $500,000 and above to the Academy in 2018. AbbVie Lilly USA, LLC Pfizer Inc. Sanofi Genzyme and Regeneron Dr. Olbricht recognized the following Sapphire Level Corporate Partners who have provided support at $250,000 - $499,999. Bristol-Myers Squibb Celgene Corporation Novartis Dr. Olbricht recognized the following Corporate Partner Circle members who have provided support at the Ruby Level $100,000 and above for three or more consecutive years. AbbVie Allergan Amgen Bristol-Myers Squibb Company Celgene Corporation Galderma Laboratories, L.P. LEO Pharma Inc. Lilly USA, LLC Novartis Ortho Dermatologics Pfizer Inc. Sanofi Genzyme and Regeneron SUN Dermatology On behalf of the more than 20,000 Academy members worldwide, Dr. Olbricht thanked these companies for their continued support of dermatology. 14 AWARD ACKNOWLEDGEMENTS Dr. Olbricht encouraged the audience to visit the Academy Awards kiosk located on the L Street Bridge, Level 2 for a listing of the Academy awardees. She stated that they were honored at the Stars of the Academy reception on Thursday. Dr. Olbricht asked the award recipients to stand to be congratulated for their exceptional efforts on behalf of the Academy and the specialty of dermatology. Dr. Olbricht then presented the Gold Medal Award to Jean L. Bolognia, MD, FAAD who made remarks of appreciation for the award. SECRETARY-TREASURER REPORT Dr. Mathes stated that the actions of the Board of Directors for the past year had been reported in Dermatology World and posted on the American Academy of Dermatology website. Disposition of the 2018 Annual Business Meeting Minutes Dr. Mathes stated the proceedings of the 2018 Annual Business Meeting were posted to the website and were included in the Annual Business Meeting booklet for membership review. In lieu of reading the minutes, a motion was made and duly seconded to approve the 2018 AAD Annual Business Meeting minutes as published. ACTION: Approved Disposition of the 2017 Audited Financial Statements for the American Academy of Dermatology (AAD) Dr. Mathes reported that the 2017 Audited Financial Statements were approved by the Academy Board of Directors and published in the November 2018 edition of Dermatology World. The 2018 report to members, which is available online, gives a brief summary of the 2017 Audited Financials, the latest 2018 forecasted results, and the 2019 Budget. Dr. Mathes then reported on details of the forecasted results, including both estimated revenues and expenses. She also summarized the key AAD/A initiatives and activities that took place in 2018 and those that are in store for 2019. She concluded by thanking the Academy for the opportunity to serve as Secretary-Treasurer and Assistant Secretary-Treasurer. Dr. Olbricht thanked Dr. Mathes for her dedicated and outstanding service in these positions. UNFINISHED BUSINESS Dr. Olbricht stated that there was no unfinished business. NEW BUSINESS Dr. Olbricht entertained questions and comments from the floor. There were none. ADJOURNMENT There being no further business, Dr. Olbricht adjourned the Annual Business Meeting of the American Academy of Dermatology at 8:56 a.m. (ET). Respectfully submitted, Barbara M. Mathes, MD, FAAD Secretary-Treasurer AMERICAN ACADEMY OF DERMATOLOGY 2020 ANNUAL BUSINESS MEETING AUGUST 22, 2020 VIRTUAL MEETING CALL TO ORDER The 2020 Annual Business Meeting of the American Academy of Dermatology (AAD) was called to order at 9:01 a.m. (CT) by Bruce H. Thiers, MD, FAAD, President. He stated that this meeting had been called pursuant to the notice requirements set forth in the Academy Bylaws and under Minnesota law. ESTABLISH QUORUM Marta J. Van Beek, MD, MPH, FAAD, Secretary-Treasurer stated that a quorum was not present (consisting of 3% of the voting members, but not less than 250 voting members). She noted that the minutes of the 2019 AAD Annual Business Meeting will be added to the agenda for approval at the 2021 Annual Business Meeting. MEMORIAL Dr. Thiers acknowledged the video that played prior to the meeting recognizing the AAD colleagues and friends who passed away since the last Annual Meeting. 15 INTRODUCTIONS AND ACKNOWLEDGMENTS Dr. Thiers asked George J. Hruza, MD, FAAD, to chair the meeting because this meeting normally would have occurred during the presidency of Dr. Hruza. Dr. Hruza thanked Dr. Thiers and noted that the Annual Business Meeting booklets were made available through the invitation to this event. The Annual Business Meeting booklet contains the minutes from the 2019 AAD and AADA Annual Business Meetings and the annual reports from the AAD/A Advisory Board, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Journal of the American Academy of Dermatology, SkinPAC and the American Board of Dermatology. Dr. Hruza acknowledged and thanked Past President, Suzanne Olbricht, MD, FAAD, Vice President, Jane M. Grant-Kels, MD, FAAD, and members of the Class of 2020 (listed below) for their exceptional service to the Academy. Erin E. Boh, MD, PhD, FAAD Kimberly J. Butterwick, MD, FAAD Linda F. Stein Gold, MD, FAAD Neil S. Sadick, MD, FAAD Terrence A. Cronin, Jr., MD, FAAD Dr. Hruza acknowledged and introduced the following Officers and Directors who took office on March 24, 2020. President, Bruce H. Thiers, MD, FAAD Vice President, Susan C. Taylor, MD, FAAD Secretary Treasurer, Marta J. Van Beek, MD, MPH, FAAD Assistant Secretary-Treasurer, Daniel D. Bennett, MD, FAAD President-Elect, Kenneth J. Tomecki, MD, FAAD Vice President-Elect, Neal Bhatia, MD, FAAD Class of 2024: Murad Alam, MD, MSCI, MBA, FAAD Cheryl M. Burgess, MD, FAAD Naomi Lawrence, MD, FAAD Amy McMichael, MD, FAAD Andrew H. Weinstein, MD, MPH, FAAD He then introduced Executive Director & CEO, Elizabeth K. Usher, MBA, and General Counsel, Robert M. Portman, JD, and thanked the Academy staff for their excellent work in putting together the VMX meeting after the Annual Meeting had to be canceled due to COVID-19 and for their outstanding service throughout the year. Dr. Hruza stated that a total of 679 applicants for Fellow, Associate, Affiliate, Adjunct, or International Fellow were accepted into membership since the 2019 Annual Meeting. RECOGNITION OF INDUSTRY Dr. Hruza recognized the following Diamond Level Corporate Partners who contributed $500,000 and above to the Academy in 2019. AbbVie Lilly USA, LLC Sanofi Genzyme/Regeneron Dr. Hruza a recognized the following Sapphire Level Corporate Partners who have provided support at $250,000 - $499,999. AMGEN Pfizer UCB Dr. Hruza recognized the following Corporate Partner Circle members who have provided support at the Ruby Level $100,000 and above for three consecutive years. AbbVie Amgen Boehringer Ingelheim Bristol-Myers Squibb Company Dermstore Janssen LEO Pharma Inc. Lilly USA, LLC Novartis Ortho Dermatologics Pfizer Inc. Sanofi Genzyme and Regeneron On behalf of the more than 20,000 Academy members worldwide, Dr. Hruza thanked these companies for their continued support of dermatology. 16 AWARD ACKNOWLEDGEMENTS Dr. Hruza encouraged the audience to visit the online Academy Awards kiosk that was associated with the virtual VMX meeting located on the AAD website. Dr. Hruza congratulated the awardees for their exceptional efforts on behalf of the Academy and the specialty of dermatology. He said that special recognition of these awardees took place in the VMX meeting. SECRETARY-TREASURER REPORT Dr. Van Beek stated that the actions of the Board of Directors for the past year had been reported in Dermatology World and posted on the American Academy of Dermatology website and that no further action was required. Disposition of the 2019 Annual Business Meeting Minutes Dr. Van Beek previously stated that the minutes of the 2019 Annual Business Meeting would be on the agenda for approval at the 2021 Annual Business Meeting. Disposition of the 2018 Audited Financial Statements for the American Academy of Dermatology (AAD) Dr. Van Beek reported that the 2018 Audited Financial Statements were approved by the Academy Board of Directors and published in the November 2019 edition of Dermatology World. Dr. Van Beek then provided a high- level financial overview of the 2019 Audited financial statements, budget, strategic plan and other activities. She reported on the budget process and explained that the budget and activities of the AAD/A are tied to the strategic plan and goals developed by the Board of Directors. She then went through several specific categories of revenue and expense. She also discussed the dramatic effect of the COVID-19 pandemic on the finances of the AAD/A, especially with the necessary cancellation of the 2020 AAD Annual Meeting. She applauded leadership and staff for pivoting quickly to organize the innovative VMX virtual meeting to ensure that AAD members had access to necessary CME. She complimented Dr. Hruza and the Ad Hoc Task Force on COVID-19 for keeping members abreast of the ongoing information, developments, and opportunities related to the pandemic. She said leadership and staff were developing a 2021 budget that will reflect the new realities of this difficult time. Dr. Van Beek discussed the next steps the Academy was taking to provide additional virtual educational content and to support members in their efforts to deal with the pandemic. UNFINISHED BUSINESS Dr. Hruza stated that there was no unfinished business. NEW BUSINESS Dr. Hruza entertained questions and comments from the attendees. There were none. Dr. Hruza reminded members that the Academy was seeking nominations for officers and directors, as well as persons interested in the Assistant SecretaryTreasurer position. He described the process for selecting the Assistant Secretary-Treasurer. ADJOURNMENT There being no further business, Dr. Thiers adjourned the Annual Business Meeting of the American Academy of Dermatology at 9:20 a.m. (CT). Respectfully submitted, Marta J. Van Beek, MD, MPH, FAAD Secretary-Treasurer 17 AADA ANNUAL BUSINESS MEETING MINUTES AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION 2019 ANNUAL BUSINESS MEETING MARCH 3, 2019 WALTER E. WASHINGTON CONVENTION CENTER WASHINGTON, DC CALL TO ORDER The 2019 Annual Business Meeting of the American Academy of Dermatology Association was called to order at 8:56 a.m. (ET) by Suzanne Olbricht, MD, FAAD, President. She stated that this meeting had been called pursuant to the notice requirements set forth in the Association Bylaws and under Minnesota law. ESTABLISH QUORUM Barbara M. Mathes, MD, Secretary-Treasurer stated that a quorum (consisting of either 3% or 250 of the voting members) was established. REPORTS TO THE MEMBERSHIP Dr. Mathes stated that the actions of the Board of Directors for the past year have been reported in Dermatology World and posted on the American Academy of Dermatology website. SECRETARY-TREASURER'S REPORT Disposition of the 2018 Annual Business Meeting Minutes Dr. Mathes stated the proceedings of the 2018 AADA Annual Business Meeting were posted to the website and included in the Annual Business Meeting booklet for membership review. In lieu of reading the minutes, a motion was made and duly seconded to approve the 2018 AADA Annual Business Meeting minutes as published. ACTION: Approved Disposition of the 2017 Audited Financial Statements for the American Academy of Dermatology Association (AADA) Dr. Mathes reported that the 2017 Audited Financial Statements had been approved by the Association Board of Directors and published in the November 2018 edition of Dermatology World. The 2018 report to members, which is available online, gives a brief summary of the 2017 Audited Financials, the latest 2018 forecasted results, and the 2019 Budget. UNFINISHED BUSINESS There was no unfinished business to consider. NEW BUSINESS Dr. Olbricht entertained questions and comments from the floor. There were none. RECOGNITION OF RETIRING BOARD OFFICERS Dr. Olbricht thanked Ted Rosen, MD, FAAD for his contribution as Vice President and presented him with an award. Dr. Olbricht thanked Dr. Mathes for her contribution as Secretary-Treasurer and presented her with an award. Dr. Rosen thanked Dr. Olbricht for her dedication and service as President this past year and presented her with an award. ADJOURNMENT There being no further business, Dr. Olbricht adjourned the Annual Business Meeting of the American Academy of Dermatology Association at 9:01 a.m. (ET). Respectfully submitted, 18 AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION 2020 ANNUAL BUSINESS MEETING AUGUST 22, 2020 VIRTUAL MEETING CALL TO ORDER The 2020 Annual Business Meeting of the American Academy of Dermatology Association (AADA) was called to order at 9:20 a.m. (CT) by Bruce H. Thiers, MD, FAAD, President. He stated that this meeting had been called pursuant to the notice requirements set forth in the Association Bylaws and under Minnesota law. Dr. Thiers asked George J. Hruza, MD, FAAD, to chair the meeting because this meeting normally would have occurred during the presidency of Dr. Hruza. ESTABLISH QUORUM Marta J. Van Beek, MD, MPH, FAAD, Secretary-Treasurer stated that a quorum was not present (consisting of 3% of the voting members, but not less than 250 voting members). REPORTS TO THE MEMBERSHIP Dr. Van Beek stated that the actions of the Board of Directors for the past year have been reported in Dermatology World and posted on the AADA section of the American Academy of Dermatology (AAD) website. SECRETARY-TREASURER REPORT Disposition of the 2019 Annual Business Meeting Minutes Dr. Van Beek noted that the minutes of the 2019 Annual Business Meeting would be on the agenda for approval at the 2021 AAD Annual Business Meeting. Disposition of the 2018 Audited Financial Statements for the American Academy of Dermatology Association (AADA) Dr. Van Beek reported that the 2018 Audited Financial Statements had been approved by the Association Board of Directors and published in the November 2019 edition of Dermatology World. She said that the statements were also available on the AAD website. UNFINISHED BUSINESS There was no unfinished business to consider. NEW BUSINESS Dr. Hruza then provided a report from the Ad Hoc Task Force on COVID-19, including a summary of the practice support information available in the COVID-19 Resource Center and the AADA's advocacy efforts on behalf of its members. He then entertained questions from the attendees. Questions were posed and responded to regarding AADA's advocacy efforts relating to relaxing prior authorization rules, plans for the 2021 Annual Meeting, options for dues relief due to financial hardship, and the American Board of Dermatology's maintenance of certification policies and requirements. Dr. Hruza then reminded attendees that the upcoming Legislative Conference in September would be virtual and gave an overview of the agenda for the conference. RECOGNITION OF RETIRING BOARD OFFICERS Dr. Hruza thanked Jane M. Grant-Kels, MD, FAAD for her contribution as Vice President and her longstanding service to the AAD/A. Dr. Grant-Kels thanked Dr. Hruza for his dedication and service as President this past year and discussed several of his accomplishments during his presidency and in leading the Ad Hoc Task Force on COVID-19 since then. ADJOURNMENT There being no further business, Dr. Thiers adjourned the Annual Business Meeting of the American Academy of Dermatology Association at 9:59 a.m. (CT). Respectfully submitted, Marta J. Van Beek, MD, MPH, FAAD Secretary-Treasurer 19 TERRENCE A. CRONIN, JR., MD, FAAD PRESIDENT-ELECT SUB-SPECIALTY(S) Medical: Surgical: Dermpath: 15% 75% 10% ALLOCATION OF TIME Academic Practice: 5% Clinical: 5% Private Practice: Clinical: Administrative: 95% 85% 10% EDUCATION Medical School: BGSM (Wake Forest University), 1992 Internship: Winston-Salem, NC 1992-1993 Residency: University of Miami 1993-1996, Chief Resident 1995-1996 CERTIFICATION ABD 1996 AREAS OF INTEREST Dermatologic Surgery, Advocacy ACADEMIC AFFILIATIONS University of Miami CLINICAL AFFILIATIONS Consultant, Hôpital Sacré Coeur, Milot, Haiti Medical staff, Holmes Regional Medical Center, Melbourne Regional Medical Center, Melbourne, FL & Jackson Memorial Hospital, Miami, FL PRESENT ACADEMIC POSITION Assistant Voluntary Professor, University of Miami ACADEMY INVOLVEMENT BOD 2016-2020 Advisory Board Chair 2016-2020 Executive Committee 2012-2020 Vice-Chair 2012-2016 Reference Committee 2006-2013, Chair 2009-2013 Dialogues in Dermatology, Editor-in-Chief 2013-2016 GAHP Council 2008-2012, 2016- present Grassroots Advocacy Committee, Chair 2008-2011 Dermatology Advocacy Network, Chair 2008-2011 6 Ad Hoc Task Forces Budget, Compensation, Member Communications, Organizational Structure, and Priorities Committees 2016-2020 Enduring Materials Committee 2013-2016 Blue Ribbon Panel on AAD Elections 2013 Election Connection Correspondent 2019-2020 ELECTED AND APPOINTED POSITIONS ASDS BOD 2014-2018 Nominating Committee 2020- present Grassroots Advocacy Workgroup Chair 2011-2014 President FSDS 2003 ASMS 2006 FSDDS 2016 WDS 2011- present HONORS AND AWARDS AAD Leadership Circle for Volunteerism: Bronze Pin 2011 AAD Presidential Service Award: Silver 2010 AAD Volunteer Recognition 2012 6 AAD Presidential Citations ASDSA Top Advocate 2019, 2020 ASMS Distinguished Service Award 2013 FSDS Surgeon of the Year 2007 FSDDS Practitioner of the Year and Sunscreen Advocate 2019 UM Surgery recognition award 2008 PUBLICATIONS/PRESENTATIONS 125+ publications RESPONSE TO THE QUESTION POSED BY THE NOMINATING COMMITTEE Of the five (5) stated priorities of the Academy, which ones are most important to you and how would you advance them? The priorities expressed in the Academy's five (5) strategic goals dovetail nicely with the main planks in my platform for president. They are (1) Excellence in dermatologic care through education and advocacy, (2) Access to dermatologic care, (3) Data driven transformation of care, (4) Unity of the specialty, and (5) Support for board-certified dermatologists leading care teams. Our 5 strategic goals are important in that they will help us to keep focus on maintaining the AAD's premier position of leadership in the areas of science, patient care, and advocacy. Promotion of these ideas will make sure the public values the expertise of our members. Our patientcentered mission must be evidence-based, compassionate, and respected. Of these priorities, one stands out as exceptionally important in light of the challenges presented by the pandemic. Unity of our specialty is my top priority. Our member-centered mission must remain inclusive, responsible, valuable, and, most importantly, enjoyable. If elected, I pledge to work hard to make sure the AAD focuses on unity while also offering the highest level of educational experiences, advocacy, practice protection, and collegiality. 20 SUSAN C. TAYLOR, MD, FAAD PRESIDENT-ELECT SUB-SPECIALTY(S) Medical: 100% ALLOCATION OF TIME Academic Practice: Clinical: Administrative: 100% 80% 20% HONORS AND AWARDS 2020 Mentor of the Year, Women's Dermatologic Society 2005, 2010, 2020 AAD Presidential Citations 2002 AAD Gold Triangle Award PUBLICATIONS/PRESENTATIONS AAD speaker 2000-Present Multiple presentations and publications nationally and internationally EDUCATION B.A. M.D. Internal Medicine Dermatology University of Pennsylvania Harvard Pennsylvania Hospital Columbia Presbyterian CERTIFICATION American Board of Internal Medicine, 1986 American Board of Dermatology, 1989 AREAS OF INTEREST Skin of Color Dermatology ACADEMIC AFFILIATIONS Department of Dermatology, Perelman School of Medicine, University of Pennsylvania CLINICAL AFFILIATIONS Hospital of the University of Pennsylvania PRESENT ACADEMIC POSITION Sandra Lazarus Professor of Dermatology, Perelman School of Medicine, University of Pennsylvania ACADEMY INVOLVEMENT 2020-Present Vice President 2020-Present Board of Directors 2020-Present Executive Committee 2020-Present Membership Committee, Ex-Officio 2020-Present Compensation Committee 2020-Present Budget Committee 2020-Present Priorities Committee 2020-Present AHTF Assistant-Secretary Treasurer Search, Chair 2020-Present Ad Hoc Nominating Committee, Chair 2020-Present WG Wes Cy Pres 2020-Present Advisory Board-Board Liaison 2019-Present WG Skin of Color Curriculum, Co-Chair 2019-Present Rapid Response Team-Corporate 2019-2020 Appointment Selection Committee 2019-Present WG Skin Cancer and SOC 2015-2017 AHTF Drug Pricing and Transparency 2013-2014 AHTF ABCDEs of Melanoma 2012-2015 Pamphlets Editorial Board 2011-2012 AHTF Transforming Communications 2011-2013 Nominating Committee, Board Elected Representative 2010-2013 Regulatory Policy Committee 2006-2011 SKINnovations Committee, Chair 2006-2011 Council on Communications 2006-2011 Board of Directors 2004-2005 AHTF Women's Health, Chair 2002-2004 Health Care Delivery Committee 1999-2001 Women's Dermatological Health ELECTED AND APPOINTED POSITIONS 2020-Present Vice President, AAD 2014-2018 BOD, WDS 2006-2011 BOD, AAD 2004-2009 BOD and President, Skin of Color Society 2008-Present American Dermatological Association RESPONSE TO THE QUESTION POSED BY THE NOMINATING COMMITTEE Of the five (5) stated priorities of the Academy, which ones are most important to you and how would you advance them? I am honored to be nominated for President of the Academy. I bring a unique set of competencies, talents, viewpoints and experiences to the position. I have traveled a great distance traversing the disparities of poverty and inequality. As I gained a sure footing through grit, determination and relentless drive, I learned to listen, sought to understand and forged common bonds with those of different perspectives, views and life experience. This foundation informs my view of how to advance the Academy's priorities to meet today's challenges and changing needs. Unity of the Specialty is the foundational and most important pillar of our 5 stated Academy priorities. As dermatologists, we are the individual threads that form the rich tapestry of the Academy. Weaving together incongruent textures poses innumerable challenges but challenges that we can overcome. As Vice President, I increased dialogue between young physicians and the Academy by conceiving of and implementing a series of Young Physician Forums. Building upon that experience, I will continue to host forums to listen and to discuss our differences and our shared goals, without vitriol or the anonymity of social networks. The goal is to facilitate inclusion and belonging, and to overcome the division in our organization. As a solo private practitioner, I have encountered the frustrations of mounting costs from governmental regulations, the loss of my patients to lesser trained non-physicians, and arbitrary payer decreased reimbursements. Based on this experience, I will work to eliminate external threats to our practices. I envision expanding Academy advocacy by rallying our patients nationwide to engage with us on critical issues and to encourage them to call, email and tweet their legislators to preserve their physician's practice domains. This transformation will require us to strategically and innovatively enhance the effectiveness of the Academy's D.C. office and coordinate with grassroots efforts at the state level. I will also guide strategic modifications and innovative expansion of our communications campaigns to educate the public about the benefits of receiving care from board-certified dermatologists and their teams. I will lead an initiative to explore how we can increase the scope of practice of dermatology. Using the model of hand surgeons who extended their scope to include surgical interventions of the elbow and shoulder, I ask provocatively should we integrate interventions involving the dental unit for our aesthetic patients; expand and utilize our knowledge of treating inflammatory dermatoses to now treat systemic inflammatory diseases like asthma or hypercholesterolemia; or extend our expertise to include the musculoskeletal system and anatomical structures including feet and hands? Our common ground is that each of us loves our specialty and honors our duty of care for our patients. To be clear, we are at an inflection point as an Academy and as individual dermatologists. Together, let's think differently and creatively to change the narrative of dermatology from one of a defensive posture to one of forward leaning transformation. I look forward to leading a united and inclusive Academy to new levels of innovation, science and success. 21 ROBERT S. KIRSNER, MD, PHD, FAAD VICE PRESIDENT-ELECT SUB-SPECIALTY(S) Medical: Surgical: 75% 25% ALLOCATION OF TIME Academic Practice: Clinical: Administrative: 100% 60% 40% EDUCATION 1980-1981 SOUTHERN ILLINOIS UNIVERSITY 1981-1984 TEXAS A&M UNIVERSITY Bachelor of Arts in Chemistry 1984-1988 UNIVERSITY OF MIAMI SCHOOL OF MEDICINE Doctor of Medicine 1996-2004 Department of Epidemiology/Public Health, Doctor of Philosophy TRAINING 1988-1990 1990-1992 1992-1995 Resident-Department of Internal Medicine UNIVERSITY OF MIAMI/JACKSON MEMORIAL HOSPITAL Fellow-Department of Dermatology and Cutaneous Surgery UNIVERSITY OF MIAMI Resident/Chief Resident-Department of Dermatology and Cutaneous Surgery UNIVERSITY OF MIAMI/JACKSON MEMORIAL HOSPITAL CERTIFICATION Diplomate, National Board of Medical Examiners Florida Medical License #ME-0058219 Diplomate, American Board of Dermatology AREAS OF INTEREST Wound Healing, Medical and Inpatient Dermatology, Skin Cancer Epidemiology ACADEMIC AFFILIATIONS University of Miami Miller School of Medicine CLINICAL AFFILIATIONS University of Miami Hospitals and Clinics Jackson Memorial Hospital PRESENT ACADEMIC POSITION Chair and Harvey Blank Professor Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine ACADEMY INVOLVEMENT 25 years of service 2001-2005 Clinical Guidelines Task Force 2002-2004 Quality of Care Task Force 2004-2008 Practice Management Task Force 2006-2010 Quality Assurance/Quality Improvement Task Force 2010-2012 Deputy Chair and Chair, Council on Education 2010-2014 Academy Oversight Committee 2017-2021 Board of Directors ELECTED AND APPOINTED POSITIONS AAD/AADA and Wound Healing Society Board of Directors President, Florida Society of Dermatology and Dermatologic Surgery and Association for the Advancement of Wound Care HONORS AND AWARDS Best Doctors in America-22 years-1998-2020 United Way Monsignor Walsh Outstanding Human Services Professional Award Alpha Omega Alpha-Faculty member award Delta Omega-Public Health Honor Society Distinguished Service Award-Florida Society of Dermatology and Dermatologic Surgery Practitioner of the Year-Florida Society of Dermatology and Dermatologic Surgery Excellence in Patient Care Award- Florida Society of Dermatology and Dermatologic Surgery PUBLICATIONS/PRESENTATIONS 576 publications H Index 74 RESPONSE TO THE QUESTION POSED BY THE NOMINATING COMMITTEE How would you advance the priorities of the Academy and the president? It would be a tremendous honor and privilege as Vice President to serve the President and members of the American Academy of Dermatology (AAD). I view my role as Vice President as supportive to the initiatives of the President and help them carry out the many missions of the AAD. Additionally, depending on the cycle of choosing the Assistant Secretary-Treasurer, and the less often, the Editor of the Journal of the American Academy of Dermatology, the AAD Vice President may serve to lead the committee to find the best candidates to present to the AAD's Board of Directors. Furthermore, as the AAD members truly are the heart and soul of the AAD, critical to my role as Vice President would be to assure that the Academy and the President understand the issues that are most critical to the members of the AAD. The AAD is an exceedingly large and complex organization. As a Department Chair, I have worked in a large organization. I have learned to balance the many needs of those I serve including patients, the faculty, residents, students, School and University administrators, alumni, as well as my local and the national dermatology communities. Being skilled at satisfying various parties and their desires, while focusing on the all-important AAD missions will be a critical asset to this job. I will bring to the Vice Presidency the energy and enthusiasm that will help advance the many missions of the AAD and the initiatives of the President. 22 VALERIE D. CALLENDER, MD, FAAD VICE PRESIDENT-ELECT SUB-SPECIALTY(S) Medical: Surgical: Pediatrics: 50% 40% 10% ALLOCATION OF TIME Academic Practice: Clinical: 10% 10% Private Practice: Clinical: Administrative: 90% 80% 10% EDUCATION Howard University College of Medicine Howard University Hospital - Dermatology CERTIFICATION Diplomate American Board of Dermatology AREAS OF INTEREST Pigmentation Disorders Hair/Scalp Disorders ACADEMIC AFFILIATIONS Howard University College of Medicine CLINICAL AFFILIATIONS Callender Dermatology & Cosmetic Center Howard University Hospital Washington Hospital Center PRESENT ACADEMIC POSITION Professor of Dermatology ACADEMY INVOLVEMENT 2020-2021 Council on Practice Management 2019-2021 Council on Education 2019-2021 Executive Committee 2019-2021 Budget Committee 2019 ILDS Delegate 2018-present JAAD Editorial Board 2019-2020 Intersociety Diversity Workgroup/Task Force 2018-2021 Council of Community, Corporate & Philanthropic Relations 2018,2019,2020 Legislative Conference 2018-2019 JAAD Mentorship Program 2018 Diversity in Dermatology Task Force 2017 President's Conference on Diversity in Dermatology 2017-2021 Board of Directors 2017,2018 Skin Cancer Screening at US Senate 2016-2019 Coding & Reimbursement Task Force 2016-2019 Core Curriculum Work Group Task Force 2015 Mastery Level Physician's Leadership Program 2015-2018 International Affairs Committee 2014 Intersociety Liaison Committee 2014,2018,2019 Skin Cancer Screening at the Maryland Senate 2012 Dermatology Research Consensus Conference 2011-2012 AHTF on Election Oversight 2010-2011 Membership Committee 2007-2010 Healthcare Delivery Committee 2007-2011 Chair, Diversity Task Force 2003-2011 Diversity Task Force 2003-2007 Women's Health Task Force 2002 Forum for Future Leaders in Dermatology ELECTED AND APPOINTED POSITIONS WDS President Secretary Board of Directors Associate Editor IJWD Chair Fundraising Committee Chair Website Committee Legacy Council SOCS President Treasurer Board of Directors Chair Development Committee NMA Dermatology Chair Vice Chair Secretary-Treasurer HONORS AND AWARDS Noah Worcester Society American Dermatologic Association Clark W. Finnerud Award WDS Mentor of the Year AAD Presidential Citation WDS President's Award AAD Members Making a Difference Award AOA Voluntary Award PUBLICATIONS/PRESENTATIONS Publications: 76 Textbooks: 1 Book Chapters: 23 Presentations: 290 RESPONSE TO THE QUESTION POSED BY THE NOMINATING COMMITTEE How would you advance the priorities of the Academy and the president? My candidacy for Vice President-Elect of the American Academy of Dermatology is predicated on my commitment to the broad-spectrum of interests in the Academy and to the verities of inclusive leadershipinclusive in gender, race, generation, and sub-specialty. The current environment dictates that we engage our members in order to meet our challenges. The rate of change in the healthcare environment is occurring at an alarming rate. There are multiple and ever-increasing proposed changes in the regulatory framework, serious and debilitating changes between the insurance companies and our members with respect to reimbursements, and destabilizing changes in the ownership structure of practices that have a profound impact on young dermatologists. However, we can concentrate our efforts on managing these continuing changes with efficiency and education. This will require a leadership that is dedicated, experienced, flexible, responsive, and thoughtful. Because all elected leadership positions within the Academy are fugacious, it is very important that members who are elected to these positions understand the Academy and its membership and can work in a cohesive team environment dedicated to the Academy's goals and priorities as promulgated by the President. The function of the Vice President is to assist the Board, Executive Committee and management in formulating and executing policies, to provide a supporting role to the President in managing the strategic plan and acting as an Ambassador for the Academy. I believe that my broad experience, commitment to the Academy and Panglossian outlook for our specialty have uniquely prepared me to undertake this role. 23 ADRIAN O. RODRIGUEZ, MD, FAAD BOARD OF DIRECTOR SUB-SPECIALTY(S) Medical: Surgical: Pediatrics: Other: 60% 25% 5% 10% ALLOCATION OF TIME Academic Practice: 5% Clinical: 5% Private Practice: Clinical: Administrative: 95% 85% 10% EDUCATION 2004-07 Resident, Dermatology, Vanderbilt University Medical Center 2003-04 Internal Medicine, Baptist Hospital, UTHSC, Nashville, TN 2003 M.D. University of Illinois College of Medicine 1994 B.S. Microbiology, University of California, San Diego CERTIFICATION 2015 Maintenance of Certification 2009 Board Certification, American Board of Dermatology 2006 TN Board of Medicine AREAS OF INTEREST Medical Dermatology (Adult and Pediatric); psoriasis, atopic dermatitis, complex medical dermatology. Surgical dermatology--skin cancer and benign lesions. Aesthetic dermatology; focus on laser resurfacing and light based technologies. ACADEMIC AFFILIATIONS Department of Medicine, University of Tennessee Health Sciences Center, Nashville, TN CLINICAL AFFILIATIONS Ascension Health Care/St. Thomas Medical Centers (Midtown and West) Southern Hills Medical Center PRESENT ACADEMIC POSITION Assistant Clinical Faculty, Dept. of Medicine, UTHSC ACADEMY INVOLVEMENT 2004-present Member 2012 Leadership Forum 2013-present Legislative Conference (annual participant) 2017 Advanced Leadership Conference 2020 State Policy Committee ELECTED AND APPOINTED POSITIONS 2009-14 President, Nashville Dermatology Society 2012-Present Tennessee Society for Laser Medicine and Surgery, Board Member 2012-Present Board of Trustees, Tennessee Dermatology Society 2015 President, Tennessee Dermatology Society 2016 Chair, Board of Trust, Tennessee Dermatology Society 2019-Present Board of Trustees, Nashville Academy of Medicine 2020-Present Board of Trustees, Tennessee Medical Association 2020-Present Chair, Education Committee, Tennessee Medical Association 2020-Present TDS representative, Coalition for Collaborative Care, TMA HONORS AND AWARDS 2007 Outstanding Research Award, Vanderbilt University Medical Center 2003 Adolph. O Rostenberg Award in Dermatology, University of Illinois 1996-2003 NIH/NCI Minority Predoctoral Fellowship National Research Service Award PUBLICATIONS/PRESENTATIONS July 2020-SCALE (Symposium for Cosmetic and Aesthetic Laser Education), Nashville, TN "Psoriasis: Challenging Areas to Treat" Psoriasis Panel Participant (Abbreviated per rules) RESPONSE TO THE QUESTION POSED BY THE NOMINATING COMMITTEE What is your primary reason for running for the Academy Board? Advocacy. Our patients and our profession require that we continue to fight for what we, as an organization, believe to be in the best interest of our patients and the protection of our profession. The complexities of our health care systems, the increases in cost, the changing structure of our practices all require the input and leadership of our organization. My involvement over many years at the state level and my active commitment to our national legislative conference and the AADA have propelled me to continue my efforts by contributing to our national organization. It would be an honor and a privilege to serve on the board for our members and our patients. 24 SARAH C. JACKSON, MD, FAAD BOARD OF DIRECTOR SUB-SPECIALTY(S) Medical: Surgical: Cosmetic: Pediatric: 50% 5% 30% 15% ALLOCATION OF TIME Private Practice: Clinical: Administrative: 100% 90% 10% EDUCATION LSUHSC DEPARTMENT OF DERMATOLOGY, New Orleans, LA 2003-2006 Dermatology Residency 2005-2006 Chief Resident LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE, New Orleans, LA 1998-2002 M.D. LOUISIANA STATE UNIVERSITY, Baton Rouge, LA 1996-1998 B.S. in Zoology, Cum Laude TEXAS CHRISTIAN UNIVERSITY, Fort Worth, TX 1994-1996 CERTIFICATION 2006, Re-Certified 2016 2003-Present American Board of Dermatology Louisiana State Medical License AREAS OF INTEREST Medical, Surgical, Cosmetic, and Laser Dermatology ACADEMIC AFFILIATIONS LSUHSC CLINICAL AFFILIATIONS 2006-present Audubon Dermatology, Practice Co-Founder 2006-present Touro Hospital, affiliated with LCMC Health PRESENT ACADEMIC POSITION 2007-present Clinical Assistant Professor, LSUHSC Department of Dermatology ACADEMY INVOLVEMENT 2006-present Fellow 2009 Leadership Forum Attendee 2015-present DermCAC Medicare Advisory Committee, Representative for Louisiana 2019 Emerging Practice Models Committee ELECTED AND APPOINTED POSITIONS 2012-2013 President, Louisiana Dermatological Society 2019-present Board of Directors, Women's Dermatologic Society 2010-2016 Louisiana State Vice Chair, Dermatology Foundation HONORS AND AWARDS 2015 Junior Achievement Rising Star Award 2005 Young Leaders in Dermatology Symposium Attendee 2002 The Adamo Memorial Award in Neural Sciences 2002-present Alpha Omega Alpha PUBLICATIONS/PRESENTATIONS 2003-present >25 presentations/publications 2020 Hooper, D. & Jackson, S. (2020). Creating a Business Plan. In J. Dover & K. Mariwalla (Eds.), The Business of Dermatology (Pages 26-30). Thieme. American Society of Dermatologic Surgery 2019 Balancing your Medical/Surgical and Cosmetic Practices, Chicago, IL 2018 Starting Your Own Dermatologic Practice: What we have learned and what we would do differently, Phoenix, AZ 2015 Utilizing your Staff in the Marketing of Your Practice: Branding, Bonuses and the Big Picture, Chicago, IL European Academy of Dermatology and Venereology 2017 Business Pearls for Busy Dermatologists, Geneva, Switzerland American Academy of Dermatology, Summer AAD 2016, 2017 Business Tips for Busy Dermatologists RESPONSE TO THE QUESTION POSED BY THE NOMINATING COMMITTEE What is your primary reason for running for the Academy Board? I want to serve the Dermatology community. My mentors inspired me to be an active part of the Academy. The future of the specialty needs a strong voice for general dermatologists in private practice on the Board of Directors. I co-founded my practice after Hurricane Katrina 15 years ago. I practice medical, cosmetic, laser, pediatric, and surgical dermatology daily. I have experienced all of the professional, business, staffing, insurance, health policy, and life balance issues faced by so many in our specialty. I am a third-generation physician who is open, results focused, and experienced in leadership. The Academy needs proven leadership that represents all aspects of our field. We need to come together as a unified specialty to strengthen dermatology for generations to come. 25 TAMMIE FERRINGER, MD, FAAD BOARD OF DIRECTOR SUB-SPECIALTY(S) Medical: Dermpath: 5% 95% ALLOCATION OF TIME Academic Practice: Clinical: Administrative: 100% 85% 15% EDUCATION MD: Medical College of Pennsylvania Residency: Geisinger Medical Center Fellowship: Medical University of South Carolina CERTIFICATION ABD Dermatology and Dermatopathology AREAS OF INTEREST Medical Education, Melanoma, Leadership Development ACADEMIC AFFILIATIONS Geisinger Commonwealth School of Medicine CLINICAL AFFILIATIONS Geisinger Medical Center PRESENT ACADEMIC POSITION Section Head and Fellowship Director, Dermatopathology ACADEMY INVOLVEMENT Scientific Assembly Committee 2018-2023, Ex-Officio 2012-2015 Leadership Development Steering Committee 2012-2019, Chair 2019-2022 JAAD Assistant Editor 2008-2018, Editorial Board 2014-present Poster Exhibits Task Force 2008-2016, Chair 2012-2016 Leadership Forum Chair 2016 Mentorship Workgroup Chair 2016-2019 2020 Summer Meeting Planning Workgroup Chair 2019-2020 Dermatopathology Rapid Response Committee 2016-2019 Priorities Committee 2019-2020 Patient Access and Payer Relations Committee Ex-Officio, 2018-2019 Core Curriculum Task Force- Dermatopathology 2017 AHTF-Reimagining the Summer Meeting 2017 Academic Dermatology Leadership Program (ADLP) Workgroup, 2010-2016 MOCmd (DSAP) Workgroup, 2007-2011 ADLP participant 2007, mentor 2016-2019 Center for Creative Leadership 2012 ELECTED AND APPOINTED POSITIONS American Society of Dermatopathology Secretary/Treasurer Executive Committee Board of Directors Program Committee Quality Committee Finance Committee Appropriate Use Committee Audit Committee Virtual Slide Library Committee Organizational Structure Committee Strategic Planning Committee Online Interactive Case Study Director FISA Committee Chair MOC Committee Chair American Board of Dermatology Board of Directors International Society of Dermatopathology Executive Committee Visiting Scholar Committee Chair ACGME Dermatology Residency Review Committee and Milestones Workgroup ABMS Committee on Continuing Certification WDS Mentorship Committee ABP Test Development and Advisory Committee Vice-Chair Cutis Editorial Board and Associate Editor HONORS AND AWARDS Walter Nickel Award for Excellence in Teaching Dermatopathology, 2019 American Dermatologic Association PUBLICATIONS/PRESENTATIONS Directed or moderated >30 courses/sessions >200 domestic and international lectures/visiting professorships Authored >75 articles and chapters Dermatopathology textbook Co-editor RESPONSE TO THE QUESTION POSED BY THE NOMINATING COMMITTEE What is your primary reason for running for the Academy Board? I prefer not to find fault or protest but to roll up my sleeves and assist in improving any situation. It has been my pleasure to hold several leadership positions in the AAD, ACGME, ABMS, WDS, ASDP, ISDP, APD, ABP, and ABD. These experiences have provided me with a solid knowledge of organization structure, bylaws, and allowed me to build a strong network with leaders in dermatology and dermatopathology, positioning me to bring representation of this portion of the membership to the board. In addition, it was my fortune to participate in the AAD Academic Dermatology Leadership Program at a formative time in my career. AAD has invested in my skills and if given the chance, I hope to provide a return on that investment. 26 ROBERT SIDBURY, MD, MPH, FAAD BOARD OF DIRECTOR SUB-SPECIALTY(S) Pediatrics: 100% ALLOCATION OF TIME Academic Practice: Clinical: Administrative: 100% 80% 20% EDUCATION BA, Duke, 1985 MD, Duke, 1993 MPH, Harvard, 2008 CERTIFICATION Dermatology Pediatric Dermatology AREAS OF INTEREST Pediatric dermatology Atopic dermatitis ACADEMIC AFFILIATIONS University of Washington School of Medicine CLINICAL AFFILIATIONS Seattle Children's Hospital PRESENT ACADEMIC POSITION Professor, Pediatrics ACADEMY INVOLVEMENT 2005-2006 Education Slide Series Task Force 2008-2012 Needs Assessment Task Force 2011-2014 Co-chair, Atopic Dermatitis Guideline Committee 2012-2014 DermClips Task Force (Editorial Board) 2014-2018 DermWorld Work Group 2015-2016 Enduring Materials Committee 2015-2017 AHTF on Food Exposure ELECTED AND APPOINTED POSITIONS 2014-present Executive Vice President, Society for Pediatric Dermatology 2017-2018 President, Washington State Dermatology Society 2014-2017 Co-chair, Scientific Advisory Committee, National Eczema Association HONORS AND AWARDS AAD Presidential Citation Best Doc, Boston Magazine, Seattle Magazine (multiple citations) Multiple Teaching Awards PUBLICATIONS/PRESENTATIONS Beyond JAAD published 4 times yearly AAD Annual meeting Hot Topics, San Antonio, 2008: Food allergy and atopic dermatitis Present at AAD annual meeting annually, summer meeting sporadically Sidbury R, Davis DM, Cohen DE et al. Guidelines of care for the management of atopic dermatitis. Section 3. Phototherapy and systemic treatment. J Am Acad Dermatol 2014;71:327-49 Sidbury R, Tom WT, Bergman J et al. Guidelines of care for the management of atopic dermatitis. Section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol 2014;71:1218-33 RESPONSE TO THE QUESTION POSED BY THE NOMINATING COMMITTEE What is your primary reason for running for the Academy Board? I care about our specialty. The AAD is a critical caretaker and advocate for our members, patients, and our place in the house of medicine. The AAD's mission is to promote excellence in patient care through "education, research, and advocacy." I believe in this mission. I am running for the Board because I feel a responsibility to give back to the specialty that has given me so much, and my experiences will help serve our diverse membership. The global pandemic has amplified the need for clearheaded leadership, and I would relish the opportunity to give back to dermatology. 27 RUTH ANN VLEUGELS, MD, MPH, MBA, FAAD BOARD OF DIRECTOR SUB-SPECIALTY(S) Medical: Pediatrics: 85% 15% ALLOCATION OF TIME Academic Practice: Clinical: Administrative: 100% 75% 25% EDUCATION 2000 University of Virginia, B.A. 2004 Vanderbilt University School of Medicine, M.D. 2005 Brigham and Women's Hospital, Intern, Internal Medicine 2008 Harvard, Resident in Dermatology 2011 Harvard School of Public Health, M.P.H. 2020 Massachusetts Institute of Technology, M.B.A. CERTIFICATION American Board of Dermatology AREAS OF INTEREST Medical dermatology, connective tissue diseases ACADEMIC AFFILIATIONS Associate Professor, Harvard Medical School CLINICAL AFFILIATIONS Brigham and Women's Hospital Boston Children's Hospital PRESENT ACADEMIC POSITION Vice-Chair for Academic Affairs Director, Autoimmune Skin Disease Program Director, Connective Tissue Disease Clinics Program Director, Dermatology-Rheumatology Fellowship ACADEMY INVOLVEMENT 2008 AAD Work Force Retreat 2008-2009 Academic Dermatology Leadership Program 2013-2014 Mentor, Diversity Mentorship Award 2014-2015 Mentor, Sulzberger Grant 2015-2018 Patient Advocate Task Force 2019-present ICD-10 Work Group ELECTED AND APPOINTED POSITIONS New England Dermatological Society 2013-present Executive Council 2016-2017 Vice-President 2017-2018 President Dermatology Foundation 2018-present Scientific Grant Review Committee Rheumatologic Dermatology Society 2013-2015 Chair, Committee on Finance 2016-2018 Resident/Fellow Committee 2020-present President-elect HONORS AND AWARDS 2010-2011 Patient Directed Investigation Grant, Dermatology Foundation 2010 Harvard Dermatology Faculty Teaching Award 2011-2012 Health Services Grant, American Skin Association 2012-2015 Medical Dermatology Career Development Award, Dermatology Foundation 2013 Harley Haynes Award for Outstanding Mentorship 2013 Brigham and Women's Hospital Pillar Junior Faculty Mentor Award 2013 Young Mentor Award, Harvard Medical School 2014 Outstanding Speaker Award, Clinical Congress of Rheumatology 2015 Donald O'Hara Faculty Prize for Excellence in Teaching 2015 Young Leadership Award, American Dermatological Association 2018 Brigham and Women's Hospital Pillar Senior Faculty Mentor Award 2020 Harvard Dermatology Award for Outstanding Mentorship PUBLICATIONS/PRESENTATIONS Presentations: regional (>50), national (>200), international (>25) Publications: focus on rare autoimmune skin diseases and emerging medical therapies, >120 peer reviewed publications. RESPONSE TO THE QUESTION POSED BY THE NOMINATING COMMITTEE What is your primary reason for running for the Academy Board? I am passionate about advocating for patients, ensuring access to care, and demonstrating the crucial role dermatologists play in an incredibly broad spectrum of disease management. In addition, I am deeply committed to bringing innovative initiatives to the Academy Board on behalf of our membership. Furthermore, I am dedicated to educating and mentoring future generations of dermatologists and to using my leadership skills to help colleagues, ensure the continued strength of our specialty, and effect change on a larger scale. 28 BRAD P. GLICK, DO, MPH, FAAD BOARD OF DIRECTOR SUB-SPECIALTY(S) Medical: Surgical: 70% 30% ALLOCATION OF TIME Academic Practice: Clinical: Administrative: 50% 40% 10% Private Practice: Clinical: Administrative: 50% 40% 10% EDUCATION Greater Miami Skin & Laser-Mt Sinai Hospital MIAMI CERTIFICATION AOBD AREAS OF INTEREST Psoriasis AD Skin Ca surgery ACADEMIC AFFILIATIONS Larkin ACGME Residency MIAMI FIU-Herbert Wertheim Col Medicine CLINICAL AFFILIATIONS Glick Skin Institute/GSI Clinical Research PRESENT ACADEMIC POSITION Residency Director-Larkin Hospital ACGME Clinical Asst Prof Dermatology-FIU/HWCOM ACADEMY INVOLVEMENT Dialogues in Dermatology Section Editor Practice Management 2020-present Associate Editor Dialogues in Dermatology, 2019-present Individual Giving Committee 2019-present AHTF on Election Oversight 2018-2019 Corporate Relations Task Force/Committee 2015-2018 ELECTED AND APPOINTED POSITIONS President, Florida Society of Dermatology and Dermatologic Surgery 2020-2021 HONORS AND AWARDS AAD Presidential Citations 2016, 2021 Noah Worcester 2019 AOCD Fellow of Distinction 2012 PUBLICATIONS/PRESENTATIONS Vasile G, Mancuso C, White R, Hanley A, Moore M, Rubenstein R, Glick B. Rare meningeal derived Malignant Hemangiopericytoma/Solitary Fibrous Tumor Grade II-III presenting as a subcutaneous mass on the scalp. JAAD Case Reports. 2020. https://doi.org/10.1016/ j.jdcr. 2020.06.042 Kleinfelder, RE, Glick, BP (2020). Complications of Non-Hyaluronic Acid Fillers. Dermatological Reviews. DOI: 10.1002/der2.26. Vasile, GF, Levin, A, Kleinfelder, RE, Rivlin, D, Glick, BP (2020). Renal Cell Carcinoma (RCC) Stain Negative Metastatic Clear Cell Renal Cell Carcinoma Masquerading as a Pyogenic Granuloma on the Scalp. SKIN The Journal of Cutaneous Medicine. 4(4):354-348. RESPONSE TO THE QUESTION POSED BY THE NOMINATING COMMITTEE What is your primary reason for running for the Academy Board? I am committed to giving back to the organization and specialty that has provided so much for me, patients and those in need. I wish to serve our members by achieving goals with a representative one voice. I will strive to make a difference by creating new initiatives and "standing up" for our specialty. I welcome the privilege to collaborate with Board member colleagues to provide rapid responses and solutions to challenges that lie ahead, including scope matters, truth in advertising, reimbursement conundrums, step therapy, prior authorizations and, most important, to foster an environment that focuses on the importance of diversity, equality and inclusivity throughout our specialty and the house of medicine. 29 SABRA SULLIVAN, MD, PHD, FAAD BOARD OF DIRECTOR SUB-SPECIALTY(S) Medical: Surgical: Pediatrics: 40% 40% 20% ALLOCATION OF TIME Academic Practice: Administrative: 10% 10% Private Practice: Clinical: Administrative: 90% 80% 10% EDUCATION Southwestern Medical School: MD, PhD (1988) PhD, Immunology (A Role for Resident, Bone Marrow-Derived Epidermal Cells in Induction and Regulation of Contact Hypersensitivity, Mentors Paul Bergstresser, MD and J. Wayne Streilein, MD) Internship, IM, Parkland Memorial Hospital (1989) Residency, Dermatology, Stanford (1992) CERTIFICATION Diplomat, American Board of Dermatology AREAS OF INTEREST Healthcare Policy, Advocacy, Immunology and Skin Cancer, Vascular Anomalies, SJS/TEN, Translational Clinical Research ACADEMIC AFFILIATIONS University Mississippi Medical Center CLINICAL AFFILIATIONS Dermatology Associates, LLC, Founding Member Baptist Medical Center Hospitals Jackson, Mississippi PRESENT ACADEMIC POSITION Adjunct Clinical Professor of Dermatology ACADEMY INVOLVEMENT Covid-19 Task Force, 2020Chair, GAHP Council 2016-2020 Chair, Congressional Policy Committee, 2012-2016 Co-Chair, State Policy Committee, 2009-2010 Chair, Practice of Medicine by Physicians & Non-Physicians Committee, 2004-2009 Grassroots Advocacy Committee, 2001-2003 Leadership Development Steering Committee, 2010-2015 Advisory Board Executive Committee, 2006-2010 8 Other AAD/A Committees and Task Force 1997-2020 ELECTED AND APPOINTED POSITIONS President, Mississippi Dermatologic Society 1997-1999, 2019-2021 VP, Mississippi Dermatologic Society 2000-2012 BOD, ADA, 2019-2021 BOD, WDS, 2000-2004 Parliamentarian, WDS 2010-2012 BOD, Noah Worcester Society Trustee, DF 2009 AADA Alternate Delegate AMA HOD 2009-2020 BOD, Mississippi Cancer Registry 2009-2012 Steering Committee, AMA SOPP Chair, SOPP Committee, MSMA 2018-2020 HONORS AND AWARDS AAD/A Presidential Citations x 4 AAD/A Advocate of the Year, 2016 DF Annenberg Circle, 2009 DF State Chair, 2009 and other years MSMA Women Leaders in Medicine Award, 2019 PUBLICATIONS/PRESENTATIONS Numerous presentations and Lectures 17 publications in peer reviewed journals (see full CV) RESPONSE TO THE QUESTION POSED BY THE NOMINATING COMMITTEE What is your primary reason for running for the Academy Board? I would be honored to serve the members of the Academy by ensuring the future of Dermatology. I have 25 years of proven leadership in advocacy. I bring a broad realistic and optimistic perspective as a woman in dermatology, a mother, and a patient. I want to use my experience to provide strategic direction to the Academy as we navigate an uncertain and exciting future. 30 MELISSA P. PILIANG, MD, FAAD BOARD OF DIRECTOR SUB-SPECIALTY(S) Medical: Dermpath: 35% 65% ALLOCATION OF TIME Academic Practice: Clinical: Administrative: 100% 90% 10% EDUCATION Cleveland Clinic Foundation: Dermatopathology Fellowship 2005-2006 Dermatology Residency 2001-2005 Indiana University School of Medicine, M.D. 2001 Purdue University B.S. 1997 CERTIFICATION Dermatology 2005, 2015 Dermatopathology 2006, 2015 AREAS OF INTEREST Alopecia, Women's Health, Androgen Disorders, Medical Dermatology, Dermatopathology ACADEMIC AFFILIATIONS Cleveland Clinic, Lerner College of Medicine of Case Western Reserve University CLINICAL AFFILIATIONS Cleveland Clinic, Cleveland, OH PRESENT ACADEMIC POSITION Dermatology and Plastic Surgery Institute, Vice Chair, Education Co-Director, Section of Dermatopathology Associate Director Dermatopathology Fellowship ACADEMY INVOLVEMENT Legislative Conference: 2008, 2016, 2017, 2019, 2020 Leadership Training: Young Leaders in Dermatology Seminar-2008 Leadership Forum 2.0-Advocacy Track-2014 Advanced Leadership Training-2018 Dermatopathology Rapid Response Committee 2012-2015 Dermatology Section Council at AMA 2013-Present Health Care Finance Committee 2016-Present Chair 2019-2021 Emerging Practice Models Committee 2019-2021 Council on GAHP 2019-2021 Annual and Summer Meeting-session coordinator, speaker ELECTED AND APPOINTED POSITIONS American Society of Dermatopathology: Trustee 2015-2016; 2018-2021 Delegate to the AMA 2013-Present Committees: Young Physician Co-Chair 2009-2011 Dermatopathology Training Directors 2009-Present Continuing Education and Research 2009-2014 Chair 2013-2014 Health Policy Work Value 2015-Present Chair 2016-Present Ohio Dermatologic Association: Trustee 2014-2020 Treasurer 2018-2019 Secretary 2018-2019 President-Elect 2019-2020 President 2020-2021 Women's Dermatologic Society: Media Relations Committee 2010-2015 Council on Communication Chair 2020-2021 Trustee 2017-2021 PUBLICATIONS/PRESENTATIONS Clark MA, Filitis D, Samie FH, Piliang M, Knackstedt TJ. Evaluating the Utility of Routine Imaging in Squamous Cell Carcinoma of the Nail Unit. Dermatol Surg. 2020-Feb 26. Sun L, Arbesman J, Piliang M. Vitamin D, autoimmunity and immune-related adverse events of immune checkpoint inhibitors. Arch Dermatol Res. 2020-Jun 9. Ibrahim O, Bayart CB, Hogan S, Piliang M, Bergfeld WF. Treatment of Alopecia Areata With Tofacitinib. JAMA Dermatol. 2017-Jun 1;153(6):600-602. RESPONSE TO THE QUESTION POSED BY THE NOMINATING COMMITTEE What is your primary reason for running for the Academy Board? My primary reason for running for the Academy Board is to serve our members. I want to advance dermatology and advocate for our members and our patients. Regardless of practice location, type or subspecialty each member's needs and opinions matter. Dermatology is best served when all dermatologists have a voice. It would be my great honor to serve on the Academy Board. 31 ANDREW F. ALEXIS, MD, MPH, FAAD NOMINATING COMMITTEE MEMBER REPRESENTATIVE SUB-SPECIALTY(S) Medical: Surgical: 65% 35% ALLOCATION OF TIME Academic Practice: Clinical: Administrative: 100% 60% 40% EDUCATION B.Sc. - McGill University M.D. - Columbia University, College of Physicians and Surgeons M.P.H. - Columbia University, Mailman School of Public Health Medical Internship (PGY-1) Saint Vincent's Hospital Dermatology Residency - New York Presbyterian Hospital (Cornell) Fellowship in Dermatopharmacology - New York University CERTIFICATION American Board of Dermatology 2003 (recertification 2012) AREAS OF INTEREST Ethnic skin disorders, Psoriasis, Acne ACADEMIC AFFILIATIONS Icahn School of Medicine at Mount Sinai CLINICAL AFFILIATIONS Mount Sinai West PRESENT ACADEMIC POSITION Professor ACADEMY INVOLVEMENT 2005 American Academy of Dermatology Leadership Forum 2007-Present Member American Academy of Dermatology 2011-2015 Chair, Diversity Task Force 2011-2015 Membership Committee ELECTED AND APPOINTED POSITIONS (2019-present) Board of Directors, American Dermatological Association (2017-2018) President, New York Dermatological Society (2012-2013) President, Manhattan Metropolitan Dermatology Society (2011-2013) Treasurer/Secretary, Skin of Color Society (2008-2009) President, New York Academy of Medicine, Dermatology Section (2008-2010) Treasurer, Dermatologic Society of Greater New York HONORS AND AWARDS 2016-Presidential Citation, American Academy of Dermatology 2014-Inducted into the American Dermatological Association 2013-Inducted into the New York Dermatological Society PUBLICATIONS/PRESENTATIONS Alexis AF et al. Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: Review and clinical practice experience. J Am Acad Dermatol 2019 Jun;80(6):1722-1729 Pandya AG, Alexis AF, Berger TG, Wintroub BU. Increasing racial and ethnic diversity in dermatology: A call to action. J Am Acad Dermatol. 2016 Mar;74(3):584. Alexis AF. Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI. Br J Dermatol. 2013;169:91 RESPONSE TO THE BALLOT QUESTION What leadership qualities are most important for officers of the American Academy of Dermatology to possess? Trust, openness to differences, and vision are among the most important qualities for officers of the Academy to possess. Academy leaders earn the trust of the membership through integrity, transparency, and effective communication. Officers that are open to and even embrace differences of opinion are particularly effective in understanding the diverse needs of the specialty and finding points of alignment that can move the organization forward. Academy leaders with a clear and compelling vision are able to engage and inspire membership. Such a leader can garner broad support for forward-thinking and innovative strategies that help to secure the longterm success of the organization and our specialty. If given the opportunity to serve, I would be committed to applying these qualities to my position. 32 CRAIG N. BURKHART, MD, MPH, MSBS, FAAD NOMINATING COMMITTEE MEMBER REPRESENTATIVE SUB-SPECIALTY(S) Medical: Surgical: Pediatrics: 10% 20% 70% ALLOCATION OF TIME Academic Practice: 4% Clinical: 2% Administrative: 2% Private Practice: Clinical: Administrative: 96% 70% 26% EDUCATION Undergrad: The University of Toledo 1997-1999 Medical School: The Medical College of Ohio 1999-2003 Preliminary: Brown University 2003-2004 Residency: The University of North Carolina at Chapel Hill 2004-2007 Fellowship (Pediatric Dermatology): Northwestern University 2007-2008 CERTIFICATION Dermatology Pediatric Dermatology AREAS OF INTEREST Pediatric Dermatology Procedural Pediatric Dermatology ACADEMIC AFFILIATIONS The University of North Carolina at Chapel Hill CLINICAL AFFILIATIONS Burkhart Pediatric & Adolescent Dermatology PRESENT ACADEMIC POSITION Adjunct Professor ACADEMY INVOLVEMENT 2011-2015 State Society Development Task Force 2012-2014 Grassroots Advocacy Workgroup 2011-2015 State Policy Committee 2015-2017 State Society Relationships Committee 2016-2017 Resident Advocacy Curriculum Workgroup 2020-present Emerging Practice Models Committee 2010-2011 Leadership Development Program participant 2012-2015 Attendee at annual Legislative Conference in and 2017 Washington, DC ELECTED AND APPOINTED POSITIONS Legislative Conference mentor (2012 and 2013) Journal of the American Academy of Dermatology Mentor (2020-present) HONORS AND AWARDS 2015: Lead advocacy effort to pass the "Jim Fulghum Teen Skin Cancer Prevention Act" (North Carolina) Associate Editor: Cutis, Journal of the American Academy of Dermatology Case Reports Section US patents (#6103248, #6417179, and #7326420) 2007: AAD Member Making a Difference Award PUBLICATIONS/PRESENTATIONS 171 Journal Articles 26 Book Chapters 5 Oral presentations at the AAD Annual Meeting Senior Editor: Essential Diagnosis: Textbook of Pediatric Dermatology Associate Editor: Krakawski Procedural Pediatric Dermatology RESPONSE TO THE BALLOT QUESTION What leadership qualities are most important for officers of the American Academy of Dermatology to possess? Officers of the American Academy of Dermatology need to embody the vision and core values of our organization. They need the intelligence, self-confidence, determination, and communication skills to lead our organization to be "recognized as the leading authority for the highest quality and compassionate dermatologic care." In their professional, organizational, and personal activities they must reflect evidence of the Academy's stated values of "patient-first, member-centric, lifelong learning, visionary leadership, professionalism, unity, and scientificallyfounded." We live in an era of accelerating change. So, among these qualities, it is especially important to have demonstrated abilities in building trust and leading change. This will require particular strengths in identifying and taking advantage of new opportunities; creating a positive and high-performance culture; and outstanding listening and communication skills. 33 Administrative Regulations Approved: Board of Directors 11/18/95 Revised: Board of Directors 6/9/01; 2/22/02; 11/23/02; 1/22/03; 12/3/05; 7/29/06; 4/21/07; 11/3/07; 8/2/08; 8/1/09; 5/22/10; 11/13/10; 8/6/11; 8/18/12; 3/2/13; 8/3/13; 8/9/14; 5/16/15; 7/30/16; 11/5/16; 3/6/17; 5/20/17; 11/4/17; 2/19/18; 4/28/18: 5/2/18; 7/28/18; 11/3/18; 7/27/19; 11/2/19; 8/15/20; 9/3/20 EXCERPT -- NOMINATION AND ELECTION PROCEDURES 9. Election Period The term "Election Period" as used in this Administrative Regulation is defined as that time between the date of identification of slated candidates by the Nominating Committee and the deadline date for receipt of ballots. This term is distinct from the term "election cycle" used in the Academy bylaws. (Article VI, Section 3 (a)). 10. Ballot and Ballot Book a. The ballot and ballot book shall be sent or otherwise be made available to all eligible voters. b. The ballot book shall be posted to the Academy Website, as soon as practicable after the announcement of the slate of candidates, but no later than the next business day after the Annual Business Meeting. Subject to the terms of Paragraph 6 of this Administrative Regulation, the ballot book shall be accompanied by each candidate's photograph, curriculum vitae, and answers to questions formulated by the Nominating Committee. 13. Authorized Election Activities by Slated Candidates Following Slate Announcement a. The two (2) president-elect candidates will record a three (3) minute interview via video chat. b. Optional Letter Each candidate may submit to the Academy one optional letter authored by the candidate in support of his/her candidacy in the below specified format. Once all letters for a specific position have been received and approved, (by or before the deadline), they will be posted collectively to the Academy's election website and will remain there throughout the election period. Membership will be notified via e-mail and fax alerts of such posting. These alerts will have a link that will take members directly to the candidate election materials. Candidates may disseminate their approved optional letter by email or post it to social media sites and may include a link to the AAD election website. Candidates who wish to disseminate their optional letter by mail to Academy members who have not provided e-mail or fax numbers are personally responsible for doing so and for all associated expenses. The Academy will provide the names and addresses of those Academy members who do not have e-mail addresses or fax numbers to candidates for a one-time use upon request. Candidates may disseminate the official Academy announcement with links to the Academy election website in their authorized communications to Academy members under this Administrative Regulation. The optional letter: c. The ballot and ballot book will be mailed to eligible voters who do not have an email address on file with the Academy. Eligible voters with an email address on file with the Academy will receive an email with an embedded link to the online ballot, ballot book and Academy Election webpage. These members will be able to vote online without their member ID and secure access code. Members may also access the online ballot and ballot book through the Academy Election Webpage. d. Upon request, eligible voters will be sent a PDF of the ballot book via email. Eligible voters also have the option to print the online ballot, complete it and mail it to the election vendor. Eligible voters may also ask to receive a mailed ballot and ballot book for future elections. · must be formatted on the candidate's letterhead or plain paper, which shall be · 8 ½" x 11" page must be typewritten in a 12-point font · may include one photograph in black and white or color that shall be no larger than 2" (wide) x 3" (high) · must not include hyperlink(s) · Candidates must forward a copy of their optional letter to the Academy office for review by the Chair of the AHTF on Election Oversight and/or the Secretary-Treasurer, no later than the Friday prior to the opening of the Academy's Annual Meeting to be disseminated to the membership. 11. Election Open Date The Academy election shall open to the membership not more than two (2) days prior to or not more than one (1) business day after the Annual Business Meeting. 12. Annual Meeting and Other Academy Election Activities a. The following election activities shall occur during the Annual Meeting: (1) slated candidates shall be acknowledged at the Annual Business Meeting (2) slated candidates for President-Elect shall be given the opportunity to make a five-minute presentation at the Annual Business Meeting (See 13. i.) (3) slated candidates shall be given the opportunity to videotape a statement (4) slated candidate videotaped statements will be posted to the Academy Website for viewing by the membership throughout the Election Period (5) slated candidate electronic Disclosure of Outside Interests Statement will be posted to the Academy Website for viewing by the membership (6) slated candidates shall receive a ribbon identifying them as a candidate for election (7) slated candidate poster boards shall be displayed (8) voting members shall be given the opportunity to vote, on their personal devices, electronically onsite (9) all candidates are encouraged to attend the young physician's reception and the Advisory Board General Meeting at the Annual Meeting b. The Academy will make every effort to assure that candidates for office do not receive inadvertent additional publicity through the reporting of Academy activities in official publications or through the day-to-day program or administrative functions in which a candidate may be involved. This rule does not preclude sitting officers and directors from performing their official duties. Notwithstanding the foregoing, candidate images may appear on non-electioneering promotional materials and videos for Academy events or programs or those produced by external parties. In addition, the names of candidates who: · are recipients of Academy awards may be published in Academy Annual Meeting publications and such candidates may receive their awards at ceremonies held during the Annual meeting (as long as no mention is made of the individual's candidacy or the election; · are speakers at the AAD/A programs may have their names listed along with the other speakers for that session and any promotional materials disseminated for that session without reference to their candidacy, but also without special mention (unless they are the featured speaker); and · appear in Academy materials having educational content i.e., interviews, articles and publications (including Dermatology World and the Journal of the American Academy of Dermatology), which will be disseminated to the membership, even if such distribution occurs during the "Election Period". (See 9) c. The Academy will inform the membership of the official authorized and recommended election activities identified herein by publishing an excerpt of this Administrative Regulation on election activities in Dermatology World in the earliest issue after the date that candidates are announced, in any issue which includes candidate position statements, in the issue that is mailed closest to the date on which the ballots are mailed, and by including the summary in the election voting packets. 34 The version of the optional letter submitted by the candidate to the Academy for posting on the Website and dissemination must be in final form. No changes to the optional letter will be allowed after it is submitted to the Academy by the candidate. The Academy will not be responsible for errors in the final version of the optional letter submitted by the candidate. c. Once the official slate of candidates is announced, candidates, and other individual members are permitted to engage in the dissemination of letters, emails, or other forms of written or electronic communications, including the slated candidate approved optional letter, in support of their candidacies or the candidates. These individuals may not be current or incoming AAD officers or directors, or members of the Nominating Committee or Ad Hoc Task Force on Election Oversight. Candidate(s) who are also current sitting AAD officers or directors may disseminate written communications in support of their own candidacy in addition to their one optional letter. They may not send communications in support of other candidates. Such communications may not criticize, defame1, or denigrate other candidates and must be consistent with the Academy's Code of Medical Ethics for Dermatologists, including the responsibility that Academy members treat each other with mutual respect in their communications with each other. Candidates cannot fund communications by others or request others to finance the cost of such communications. Slated candidates may include links in their communications to the Academy election webpage containing their optional letter (see Section 13. b) or video (see Section 13. i - j). Individual members, other than candidates writing on their own behalf, may not send out communications in support of candidates using letterhead with the branded name or logo of a group or organization, as defined in Section 13.h. Current and incoming AAD officers and directors may socially introduce2 an individual candidate while attending the AAD Annual meeting but may not actively campaign for3 them. During the nomination period, potential nominees and candidates may not engage in any such election-related communications other than direct, one-on-one, personal communications with friends and colleagues until the official slate of candidates is announced by the Academy. d. Candidates may give presentations in support of their candidacy at local, state, regional and sub-specialty dermatologic meetings if all other slated candidates for the position have been invited to present. To ensure all candidates for the same position are invited, these invitations should be directed to the Academy's Executive Office at candidates@aad.org. At these sessions, candidates' presentations should focus on their views regarding relevant Academy policy. e. Candidates may participate in social media discussions. However, when responding to questions on issues that are of relevance to their candidacy, candidates are strongly encouraged to refer their responses back to the Academy's social media election site. In no circumstances may candidates criticize, defame or denigrate other candidates in their social media discussions. f. Candidates may give educational, scientific, or clinical presentations or interviews at dermatologic meetings or in related publications. However, presentations in these circumstances may not contain any political or electioneering content, and the candidates must refrain from mentioning their candidacy, other candidates, or the election. Other similar presentations or interviews may also be permitted as long as they contain no reference to the current election. g. Distribution by candidates of flyers, gifts, trinkets, pins, ribbons, balloons, and other similar items in support of the candidate is prohibited. b. must be received or electronically posted by a date designated therein, which date shall be within two weeks of the opening date of the election. h. Members and groups or organizations are encouraged to submit questions to the Nominating Committee for possible selection for response from candidates in the ballot book. Groups or organizations may encourage their members or employed, affiliated, or subscribing dermatologists to vote in the Academy election and may publish or otherwise disseminate the official list of slated candidates to their members or employed, affiliated, or subscribing dermatologists and provide links to the candidates' materials on the Academy election website, but groups or organizations are strongly discouraged from disseminating letters, emails, or other forms of written or electronic communications endorsing, campaigning for, or otherwise supporting particular candidates or identifying them as members, employees, affiliates, or subscribers of their groups or organizations. Candidates may not solicit and should affirmatively discourage endorsements or other support of their candidacies from groups or organizations. For purposes of this Section 13.h., "groups" or "organizations" include formal or informal groups or organizations with three (3) or more members or employed, affiliated, or subscribing dermatologists who are AAD voting members, including but not limited to, national, state or local dermatology or other medical societies; dermatology departments in academic medical centers, medical clinics, or hospitals; dermatology practices (regardless of type of ownership); or social media groups, or other for profit or non-profit corporate entity that meets the requirements of this section. i. President-Elect Candidates Presentation President-Elect candidates have the option of giving a (5) five-minute presentation at the Annual Business Meeting. This presentation must be submitted in final written format to the Executive Office no later than (5) five days prior to the Annual Meeting. Candidates should indicate the format they will use to give their presentation i.e., PowerPoint, teleprompter. The final version of each President-Elect Candidate's presentation will be posted to the Academy Website as submitted. President-elect Candidates are encouraged to participate in a rehearsal that is held at the Annual Meeting. During rehearsal, speeches will be timed to ensure they are within the five-minute time limit. There will be a warning light at the podium to notify the candidates during their live speeches when they have thirty seconds remaining in their five-minute time limit. In fairness to both candidates, the microphone will be shut off at or very shortly after the time limit has elapsed. Each President-elect candidate's five-minute videotaped speech will be posted to the Academy's election Website together. j. Slated Candidate Videotaped Statement Slated Candidates for the position of Vice President-elect, Director and Nominating Committee member representative are encouraged to participate in a videotaped statement to be recorded no later than the Friday prior to the opening of the Annual Meeting. The Academy will post the videotape and corresponding written Candidate Statements to the Academy election website for viewing by the membership throughout the Election Period. This is in addition to, and not in place of the optional candidate letter. The content of the videotaped statement will be the decision of the individual candidate. Candidates are responsible for assuring that the statement is done in a professional manner, i.e., no dancing, music, dogs doing tricks, etc. and will fit into the time limits listed below. Candidates are encouraged to rehearse their statements. The time that has been allotted for the candidate videotaped statement is as follows: Vice President-Elect One Minute c. must not contain write-in votes for Officers and Nominating Committee member representative positions. d. may contain a vote for one (1) eligible Director write-in candidate. e. may not exceed four (4) votes for Directors inclusive of one (1) Director write-in candidate. 16. Announcement of Election Results Successful candidates shall be announced as soon as practicable after the ballot return date. 17. Official Election Candidate Results The official results of each election certified by the independent election service are kept on file at the Academy office. Each candidate may verbally receive their numerical results of the election in which the individual was a candidate by contacting the Secretary-Treasurer or Assistant Secretary-Treasurer. An unsuccessful Director candidate, from the current election period, may verbally request the numerical result of the Director elected to the fourth seat. The Secretary-Treasurer or Assistant Secretary-Treasurer may verbally provide the numerical result without identifying the elected Director by name. 18. Assumption of Office4 Successful candidates shall assume office at the conclusion of the Annual Meeting following the election. 19. Manner of Notice and Announcement Notice(s) and Announcement(s) required by this Administrative Regulation shall be in writing and, unless otherwise specified by the Academy Bylaws or this Administrative Regulation, may be affected by publication in an official Academy or Association publication, by United States mail, or by facsimile, or electronic transmission. 20. Ad Hoc Task Force on Election Oversight An ad hoc task force will be appointed each year prior to the Call for Nominations, to monitor the Academy's election process and election activities. The ad hoc task force will be chaired by the Immediate Past President holding office when slated candidates are announced, and will be further comprised of the President, Secretary-Treasurer or Assistant Secretary-Treasurer, and the following individuals appointed by the President: a past member of the Board of Directors, a recent past member of the Nominating Committee, a member of the Advisory Board, and a recent unsuccessful candidate. The president may appoint up to two (2) additional members at his/her discretion. Members asked to serve on the AHTF on Election Oversight should not accept the appointment if they anticipate becoming a candidate in the upcoming election. Upon acceptance of the AHTF appointment, the member must remain neutral throughout their term, which includes, but is not limited to, the nominating process and Election Period. The AHTF members are restricted from submitting nominations, supporting nominees, writing letters or speaking in support of any nominee, potential candidate, slated candidate or write-in candidate running for office. The Ad Hoc Task Force on Election Oversight will report any recommendations for sanctions to the Board of Directors. At the end of the election process, the Ad Hoc Task Force will present a formal report to the Board of Directors and include any recommendations that it may have for revisions to existing regulations. Director 45 Seconds 21. Member and Candidate Sanctions for Failure to Comply with Regulations Nominating Committee Member Representative 30 Seconds k. Candidates will be asked to complete a questionnaire on the election process prior to the announcement of the final results of the election. The Ad Hoc Task Force on Election Oversight is responsible for addressing inappropriate communications and works with the member, individual, slated or write-in candidate(s) to resolve the issue. The Ad Hoc Task Force has the authority to block a member's or candidate's access to the AAD Election Connection! Should 14. Authorized Election Activities by Director Write-in Candidates following Slate further review or sanctions be required, the Ad Hoc Task Force will refer the issue Announcement to the Board of Directors or the Professionalism and Ethics Committee. Candidates a. Unsuccessful nominees who wish to be a Director write-in candidate, have been or other members may not file a complaint with the Professionalism and Ethics vetted by the Nominating Committee, and are a Fellow in good standing with Committee based on an alleged violation of this Administrative Regulation unless the Academy, are required to submit their name in writing to the American the Ad Hoc Task Force has first found that such violation occurred and that referral Academy of Dermatology, attention Secretary-Treasurer, by a designated date to the Professionalism and Ethics Committee is appropriate. The foregoing does that is ten (10) days prior to the opening of the election. Such individuals will be eligible to run as a Director write-in candidate, subject to the same background checks as conducted for short-listed Director candidates. Based on the results of such additional vetting, written approval by the Secretary-Treasurer will be granted after the Academy's official slate of candidates is announced. b. Director Write-in candidates are also subject to the rules outlined in Paragraph 13. c through 13. h and k, including without limitation the restriction on any election-related communications in support of their candidacy prior to the announcement of the official slate of candidates. not prevent candidates and other members from filing complaints directly with the Professionalism and Ethics Committee based on election-related conduct that they believe violates the Administrative Regulation on Code of Medical Ethics for Dermatologists for a reason other than a violation of this administrative regulation. Slated and write-in candidate(s), who are found, by a majority vote of the Board of Directors, to be in violation of the above regulations may, at the Board's discretion, be subject to sanctions, including but not limited to, removal from the ballot and/ or nullification of votes received. c. Director Write-in candidates' electronic Disclosure Statements of Potential Conflict of Interest, photograph, curriculum vitae and the answer to the The Board of Directors retains discretion to alter the dates within this administrative regulation to accommodate special circumstances. Nominating Committee question will be posted to the Academy Website for viewing by the membership on a webpage linked off of the Academy's official 1 Definition of written and oral defamation: The act of making and publishing (to one or more third parties) slated candidate's webpage. d. Director Write-in candidates will be invited to participate on the candidate briefing call; their names will not appear in the ballot book. untrue statements of fact about another which damages his/her reputation. If the defamatory statement is printed or broadcast over the media, including social media, it is libel and, if only oral, it is slander. The following are examples of what constitutes a social introduction and of possible campaign activities. 2 Socially introduce A member encounters a candidate while attending a function (social or otherwise) at the annual meeting. The encounter happens at unpredicted times and locations i.e., before/after a session or meeting, dinners, e. Director write-in candidates shall receive a distinctive ribbon identifying them as such to wear at the Annual meeting. receptions, etc. The member is allowed to casually introduce the candidate. 3 Campaign for When a candidate and member prepare a plan of action so they can attend as many of the same functions together. The member would then introduce the candidate to many colleagues (at each function) and ask for their vote or remind them 15. Ballot Return Date To be valid and in accordance with Paragraph 17 of this Administrative Regulation, ballots: to vote. A candidate could also stand by an elevator/escalator or in a busy area of the convention center for an extended period-of-time with a member who introduces him/her while asking for their vote or reminding them to vote. 4 The fiduciary obligations of elected officers and directors generally apply when they officially take office at the end of the Annual Meeting following their election. However, these individuals must abide by the fiduciary a. must be submitted online or sent directly to the independent election service obligations of officers and directors during the year following their election and before they formally take office to the extent that they are involved in any Board of Directors meetings, activities, or decisions, particularly with respect designated therein. 35 to confidential information.

Microsoft Word for Microsoft 365

jtenut

2021 AAD ELECTION BALLOT BOOK